CN105412143A - Oral cavity composition containing polyguanidine compounds and preparation and application method of oral cavity composition - Google Patents
Oral cavity composition containing polyguanidine compounds and preparation and application method of oral cavity composition Download PDFInfo
- Publication number
- CN105412143A CN105412143A CN201510570435.4A CN201510570435A CN105412143A CN 105412143 A CN105412143 A CN 105412143A CN 201510570435 A CN201510570435 A CN 201510570435A CN 105412143 A CN105412143 A CN 105412143A
- Authority
- CN
- China
- Prior art keywords
- oral cavity
- calcium
- gegenion
- polyguanidine
- cavity composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 169
- 210000000214 mouth Anatomy 0.000 title claims abstract description 119
- 238000000034 method Methods 0.000 title claims abstract description 69
- 150000001875 compounds Chemical class 0.000 title claims abstract description 64
- 238000002360 preparation method Methods 0.000 title abstract description 21
- 239000000463 material Substances 0.000 claims abstract description 52
- 238000011282 treatment Methods 0.000 claims abstract description 44
- 210000000515 tooth Anatomy 0.000 claims abstract description 42
- 208000002925 dental caries Diseases 0.000 claims abstract description 22
- 230000002265 prevention Effects 0.000 claims abstract description 13
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical group [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 claims description 40
- -1 poly-aminoalkyl acrylamide Chemical compound 0.000 claims description 35
- ZRALSGWEFCBTJO-UHFFFAOYSA-N guanidine group Chemical group NC(=N)N ZRALSGWEFCBTJO-UHFFFAOYSA-N 0.000 claims description 29
- 230000000844 anti-bacterial effect Effects 0.000 claims description 20
- 229910000019 calcium carbonate Inorganic materials 0.000 claims description 20
- 239000011575 calcium Substances 0.000 claims description 19
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims description 16
- 239000002253 acid Substances 0.000 claims description 16
- 229910052791 calcium Inorganic materials 0.000 claims description 16
- 235000002949 phytic acid Nutrition 0.000 claims description 14
- 150000003839 salts Chemical class 0.000 claims description 13
- IMQLKJBTEOYOSI-GPIVLXJGSA-N Inositol-hexakisphosphate Chemical compound OP(O)(=O)O[C@H]1[C@H](OP(O)(O)=O)[C@@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@@H]1OP(O)(O)=O IMQLKJBTEOYOSI-GPIVLXJGSA-N 0.000 claims description 11
- 229920006395 saturated elastomer Polymers 0.000 claims description 10
- 229910019142 PO4 Inorganic materials 0.000 claims description 9
- 125000000217 alkyl group Chemical group 0.000 claims description 9
- 235000021317 phosphate Nutrition 0.000 claims description 9
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 8
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 claims description 8
- 239000001506 calcium phosphate Substances 0.000 claims description 8
- 159000000007 calcium salts Chemical class 0.000 claims description 8
- 239000010452 phosphate Substances 0.000 claims description 8
- 229910052698 phosphorus Inorganic materials 0.000 claims description 8
- 239000011574 phosphorus Substances 0.000 claims description 8
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 7
- 150000003141 primary amines Chemical class 0.000 claims description 7
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 claims description 6
- 210000000981 epithelium Anatomy 0.000 claims description 6
- 229910052736 halogen Inorganic materials 0.000 claims description 6
- 150000002367 halogens Chemical class 0.000 claims description 6
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 claims description 6
- 229920000642 polymer Polymers 0.000 claims description 6
- 230000001954 sterilising effect Effects 0.000 claims description 6
- 238000004659 sterilization and disinfection Methods 0.000 claims description 6
- 208000004434 Calcinosis Diseases 0.000 claims description 5
- 230000002308 calcification Effects 0.000 claims description 5
- WUKWITHWXAAZEY-UHFFFAOYSA-L calcium difluoride Chemical compound [F-].[F-].[Ca+2] WUKWITHWXAAZEY-UHFFFAOYSA-L 0.000 claims description 5
- 229910001634 calcium fluoride Inorganic materials 0.000 claims description 5
- 125000000524 functional group Chemical group 0.000 claims description 5
- 230000008685 targeting Effects 0.000 claims description 5
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 claims description 5
- KXDHJXZQYSOELW-UHFFFAOYSA-M Carbamate Chemical compound NC([O-])=O KXDHJXZQYSOELW-UHFFFAOYSA-M 0.000 claims description 4
- 201000011180 Dental Pulp Calcification Diseases 0.000 claims description 4
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 4
- 150000001408 amides Chemical class 0.000 claims description 4
- 150000001412 amines Chemical class 0.000 claims description 4
- 239000004202 carbamide Substances 0.000 claims description 4
- 150000002148 esters Chemical class 0.000 claims description 4
- 235000013305 food Nutrition 0.000 claims description 4
- 239000001257 hydrogen Substances 0.000 claims description 4
- 229910052739 hydrogen Inorganic materials 0.000 claims description 4
- 238000011321 prophylaxis Methods 0.000 claims description 4
- 239000000758 substrate Substances 0.000 claims description 4
- 150000003568 thioethers Chemical class 0.000 claims description 4
- 238000004448 titration Methods 0.000 claims description 4
- 229920001661 Chitosan Polymers 0.000 claims description 3
- 235000019739 Dicalciumphosphate Nutrition 0.000 claims description 3
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 claims description 3
- IMQLKJBTEOYOSI-UHFFFAOYSA-N Phytic acid Natural products OP(O)(=O)OC1C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C1OP(O)(O)=O IMQLKJBTEOYOSI-UHFFFAOYSA-N 0.000 claims description 3
- HFIGWKOFZLNOQK-UHFFFAOYSA-K [O-]P([O-])(=O)OP(=O)([O-])O.[Ca+2].[Na+] Chemical compound [O-]P([O-])(=O)OP(=O)([O-])O.[Ca+2].[Na+] HFIGWKOFZLNOQK-UHFFFAOYSA-K 0.000 claims description 3
- 229940095626 calcium fluoride Drugs 0.000 claims description 3
- HIAAVKYLDRCDFQ-UHFFFAOYSA-L calcium;dodecanoate Chemical compound [Ca+2].CCCCCCCCCCCC([O-])=O.CCCCCCCCCCCC([O-])=O HIAAVKYLDRCDFQ-UHFFFAOYSA-L 0.000 claims description 3
- HRBZRZSCMANEHQ-UHFFFAOYSA-L calcium;hexadecanoate Chemical compound [Ca+2].CCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCC([O-])=O HRBZRZSCMANEHQ-UHFFFAOYSA-L 0.000 claims description 3
- NEFBYIFKOOEVPA-UHFFFAOYSA-K dicalcium phosphate Chemical compound [Ca+2].[Ca+2].[O-]P([O-])([O-])=O NEFBYIFKOOEVPA-UHFFFAOYSA-K 0.000 claims description 3
- 229940038472 dicalcium phosphate Drugs 0.000 claims description 3
- 229910000390 dicalcium phosphate Inorganic materials 0.000 claims description 3
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 3
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 claims description 3
- 229960000367 inositol Drugs 0.000 claims description 3
- 239000004571 lime Substances 0.000 claims description 3
- 239000000467 phytic acid Substances 0.000 claims description 3
- 229940068041 phytic acid Drugs 0.000 claims description 3
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 claims description 3
- 235000019731 tricalcium phosphate Nutrition 0.000 claims description 3
- 229940078499 tricalcium phosphate Drugs 0.000 claims description 3
- 229910000391 tricalcium phosphate Inorganic materials 0.000 claims description 3
- RAXXELZNTBOGNW-UHFFFAOYSA-N 1H-imidazole Chemical compound C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 claims description 2
- 108010039918 Polylysine Proteins 0.000 claims description 2
- 125000001118 alkylidene group Chemical group 0.000 claims description 2
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 2
- 150000007942 carboxylates Chemical group 0.000 claims description 2
- 229940112822 chewing gum Drugs 0.000 claims description 2
- 235000015218 chewing gum Nutrition 0.000 claims description 2
- 229920000656 polylysine Polymers 0.000 claims description 2
- 229920002714 polyornithine Polymers 0.000 claims description 2
- 108010055896 polyornithine Proteins 0.000 claims description 2
- 229920002554 vinyl polymer Polymers 0.000 claims description 2
- 125000006552 (C3-C8) cycloalkyl group Chemical group 0.000 claims 1
- 125000004350 aryl cycloalkyl group Chemical group 0.000 claims 1
- 230000000845 anti-microbial effect Effects 0.000 abstract description 9
- 208000028169 periodontal disease Diseases 0.000 abstract description 9
- 210000003097 mucus Anatomy 0.000 abstract description 5
- 229920000768 polyamine Polymers 0.000 abstract description 5
- 230000004048 modification Effects 0.000 abstract description 2
- 238000012986 modification Methods 0.000 abstract description 2
- 230000001070 adhesive effect Effects 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 description 56
- 239000011521 glass Substances 0.000 description 46
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 40
- 239000008187 granular material Substances 0.000 description 18
- 239000000377 silicon dioxide Substances 0.000 description 18
- 230000000694 effects Effects 0.000 description 16
- 239000002245 particle Substances 0.000 description 16
- 238000000227 grinding Methods 0.000 description 14
- 235000012239 silicon dioxide Nutrition 0.000 description 12
- 239000004094 surface-active agent Substances 0.000 description 12
- 210000004268 dentin Anatomy 0.000 description 11
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 11
- 208000002064 Dental Plaque Diseases 0.000 description 10
- 201000010099 disease Diseases 0.000 description 10
- 150000002500 ions Chemical class 0.000 description 10
- 239000011734 sodium Substances 0.000 description 10
- CHJJGSNFBQVOTG-UHFFFAOYSA-N N-methyl-guanidine Natural products CNC(N)=N CHJJGSNFBQVOTG-UHFFFAOYSA-N 0.000 description 9
- 230000004071 biological effect Effects 0.000 description 9
- SWSQBOPZIKWTGO-UHFFFAOYSA-N dimethylaminoamidine Natural products CN(C)C(N)=N SWSQBOPZIKWTGO-UHFFFAOYSA-N 0.000 description 9
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 8
- 235000001465 calcium Nutrition 0.000 description 8
- 210000003298 dental enamel Anatomy 0.000 description 8
- 210000001519 tissue Anatomy 0.000 description 8
- RYJDNPSQBGFFSF-WCCKRBBISA-N (2s)-2-amino-5-(diaminomethylideneamino)pentanoic acid;carbonic acid Chemical compound OC(O)=O.OC(=O)[C@@H](N)CCCNC(N)=N RYJDNPSQBGFFSF-WCCKRBBISA-N 0.000 description 7
- 208000006558 Dental Calculus Diseases 0.000 description 7
- 239000000551 dentifrice Substances 0.000 description 7
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 description 7
- 239000000047 product Substances 0.000 description 7
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 6
- 230000015572 biosynthetic process Effects 0.000 description 6
- 238000005282 brightening Methods 0.000 description 6
- 239000003153 chemical reaction reagent Substances 0.000 description 6
- 229910052500 inorganic mineral Inorganic materials 0.000 description 6
- 235000010755 mineral Nutrition 0.000 description 6
- 239000011707 mineral Substances 0.000 description 6
- 229910052708 sodium Inorganic materials 0.000 description 6
- 235000015424 sodium Nutrition 0.000 description 6
- ODINCKMPIJJUCX-UHFFFAOYSA-N Calcium oxide Chemical compound [Ca]=O ODINCKMPIJJUCX-UHFFFAOYSA-N 0.000 description 5
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 5
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 5
- YCKRFDGAMUMZLT-UHFFFAOYSA-N Fluorine atom Chemical compound [F] YCKRFDGAMUMZLT-UHFFFAOYSA-N 0.000 description 5
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 5
- RVGRUAULSDPKGF-UHFFFAOYSA-N Poloxamer Chemical compound C1CO1.CC1CO1 RVGRUAULSDPKGF-UHFFFAOYSA-N 0.000 description 5
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 5
- 239000004141 Sodium laurylsulphate Substances 0.000 description 5
- 239000013543 active substance Substances 0.000 description 5
- 239000000654 additive Substances 0.000 description 5
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 5
- 229920001577 copolymer Polymers 0.000 description 5
- 229910052731 fluorine Inorganic materials 0.000 description 5
- 239000011737 fluorine Substances 0.000 description 5
- 229960000502 poloxamer Drugs 0.000 description 5
- 229920001983 poloxamer Polymers 0.000 description 5
- 210000003296 saliva Anatomy 0.000 description 5
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 5
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 4
- 229910004261 CaF 2 Inorganic materials 0.000 description 4
- KRHYYFGTRYWZRS-UHFFFAOYSA-M Fluoride anion Chemical compound [F-] KRHYYFGTRYWZRS-UHFFFAOYSA-M 0.000 description 4
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 4
- ABCWLNFYJOPDBF-UHFFFAOYSA-N [Na].[P].[Ca] Chemical compound [Na].[P].[Ca] ABCWLNFYJOPDBF-UHFFFAOYSA-N 0.000 description 4
- 230000000996 additive effect Effects 0.000 description 4
- 239000011230 binding agent Substances 0.000 description 4
- 239000000378 calcium silicate Substances 0.000 description 4
- 229910052918 calcium silicate Inorganic materials 0.000 description 4
- 150000001720 carbohydrates Chemical class 0.000 description 4
- RRAFCDWBNXTKKO-UHFFFAOYSA-N eugenol Chemical compound COC1=CC(CC=C)=CC=C1O RRAFCDWBNXTKKO-UHFFFAOYSA-N 0.000 description 4
- 239000006072 paste Substances 0.000 description 4
- 239000000843 powder Substances 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- 241000894006 Bacteria Species 0.000 description 3
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 3
- 229910052783 alkali metal Inorganic materials 0.000 description 3
- 235000001014 amino acid Nutrition 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- 230000001580 bacterial effect Effects 0.000 description 3
- 239000002585 base Substances 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 230000000903 blocking effect Effects 0.000 description 3
- 239000006227 byproduct Substances 0.000 description 3
- BRPQOXSCLDDYGP-UHFFFAOYSA-N calcium oxide Chemical compound [O-2].[Ca+2] BRPQOXSCLDDYGP-UHFFFAOYSA-N 0.000 description 3
- 239000000292 calcium oxide Substances 0.000 description 3
- 239000001768 carboxy methyl cellulose Substances 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 238000005115 demineralization Methods 0.000 description 3
- 230000002328 demineralizing effect Effects 0.000 description 3
- 239000001177 diphosphate Substances 0.000 description 3
- 229940091249 fluoride supplement Drugs 0.000 description 3
- 208000007565 gingivitis Diseases 0.000 description 3
- BHEPBYXIRTUNPN-UHFFFAOYSA-N hydridophosphorus(.) (triplet) Chemical compound [PH] BHEPBYXIRTUNPN-UHFFFAOYSA-N 0.000 description 3
- OSWPMRLSEDHDFF-UHFFFAOYSA-N methyl salicylate Chemical compound COC(=O)C1=CC=CC=C1O OSWPMRLSEDHDFF-UHFFFAOYSA-N 0.000 description 3
- 238000006386 neutralization reaction Methods 0.000 description 3
- 229910052757 nitrogen Inorganic materials 0.000 description 3
- 235000015097 nutrients Nutrition 0.000 description 3
- 239000003921 oil Substances 0.000 description 3
- 230000003239 periodontal effect Effects 0.000 description 3
- 239000000546 pharmaceutical excipient Substances 0.000 description 3
- 229910052700 potassium Inorganic materials 0.000 description 3
- 239000011591 potassium Substances 0.000 description 3
- KKCBUQHMOMHUOY-UHFFFAOYSA-N sodium oxide Chemical compound [O-2].[Na+].[Na+] KKCBUQHMOMHUOY-UHFFFAOYSA-N 0.000 description 3
- 229910001948 sodium oxide Inorganic materials 0.000 description 3
- 210000004872 soft tissue Anatomy 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 238000003786 synthesis reaction Methods 0.000 description 3
- 239000004408 titanium dioxide Substances 0.000 description 3
- 229940034610 toothpaste Drugs 0.000 description 3
- 239000000606 toothpaste Substances 0.000 description 3
- 210000005239 tubule Anatomy 0.000 description 3
- XHXUANMFYXWVNG-ADEWGFFLSA-N (-)-Menthyl acetate Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@H]1OC(C)=O XHXUANMFYXWVNG-ADEWGFFLSA-N 0.000 description 2
- KJPRLNWUNMBNBZ-QPJJXVBHSA-N (E)-cinnamaldehyde Chemical compound O=C\C=C\C1=CC=CC=C1 KJPRLNWUNMBNBZ-QPJJXVBHSA-N 0.000 description 2
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 2
- RCORSHSFJCXHTF-UHFFFAOYSA-N 2-ethenyl-1,3-dioxan-5-ol Chemical compound OC1COC(C=C)OC1 RCORSHSFJCXHTF-UHFFFAOYSA-N 0.000 description 2
- XGRSAFKZAGGXJV-UHFFFAOYSA-N 3-azaniumyl-3-cyclohexylpropanoate Chemical compound OC(=O)CC(N)C1CCCCC1 XGRSAFKZAGGXJV-UHFFFAOYSA-N 0.000 description 2
- ALYNCZNDIQEVRV-UHFFFAOYSA-N 4-aminobenzoic acid Chemical compound NC1=CC=C(C(O)=O)C=C1 ALYNCZNDIQEVRV-UHFFFAOYSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 108010011485 Aspartame Proteins 0.000 description 2
- 239000001736 Calcium glycerylphosphate Substances 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- NPBVQXIMTZKSBA-UHFFFAOYSA-N Chavibetol Natural products COC1=CC=C(CC=C)C=C1O NPBVQXIMTZKSBA-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 2
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 2
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 2
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 2
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 2
- 229940090898 Desensitizer Drugs 0.000 description 2
- 239000005770 Eugenol Substances 0.000 description 2
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 2
- 229930195725 Mannitol Natural products 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- UVMRYBDEERADNV-UHFFFAOYSA-N Pseudoeugenol Natural products COC1=CC(C(C)=C)=CC=C1O UVMRYBDEERADNV-UHFFFAOYSA-N 0.000 description 2
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 2
- 229910004298 SiO 2 Inorganic materials 0.000 description 2
- 229920002125 Sokalan® Polymers 0.000 description 2
- 206010072665 Tooth demineralisation Diseases 0.000 description 2
- AXMVYSVVTMKQSL-UHFFFAOYSA-N UNPD142122 Natural products OC1=CC=C(C=CC=O)C=C1O AXMVYSVVTMKQSL-UHFFFAOYSA-N 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 230000002378 acidificating effect Effects 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 239000003513 alkali Substances 0.000 description 2
- 229910021529 ammonia Inorganic materials 0.000 description 2
- 239000003945 anionic surfactant Substances 0.000 description 2
- 230000002421 anti-septic effect Effects 0.000 description 2
- 239000000605 aspartame Substances 0.000 description 2
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 2
- 235000010357 aspartame Nutrition 0.000 description 2
- 229960003438 aspartame Drugs 0.000 description 2
- HUMNYLRZRPPJDN-UHFFFAOYSA-N benzaldehyde Chemical compound O=CC1=CC=CC=C1 HUMNYLRZRPPJDN-UHFFFAOYSA-N 0.000 description 2
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 2
- JUNWLZAGQLJVLR-UHFFFAOYSA-J calcium diphosphate Chemical compound [Ca+2].[Ca+2].[O-]P([O-])(=O)OP([O-])([O-])=O JUNWLZAGQLJVLR-UHFFFAOYSA-J 0.000 description 2
- UHHRFSOMMCWGSO-UHFFFAOYSA-L calcium glycerophosphate Chemical compound [Ca+2].OCC(CO)OP([O-])([O-])=O UHHRFSOMMCWGSO-UHFFFAOYSA-L 0.000 description 2
- 229940095618 calcium glycerophosphate Drugs 0.000 description 2
- 235000019299 calcium glycerylphosphate Nutrition 0.000 description 2
- 229910000389 calcium phosphate Inorganic materials 0.000 description 2
- 235000011010 calcium phosphates Nutrition 0.000 description 2
- 229940043256 calcium pyrophosphate Drugs 0.000 description 2
- 235000014633 carbohydrates Nutrition 0.000 description 2
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 2
- 239000004075 cariostatic agent Substances 0.000 description 2
- 239000000969 carrier Substances 0.000 description 2
- 239000003093 cationic surfactant Substances 0.000 description 2
- 150000001768 cations Chemical class 0.000 description 2
- 210000000170 cell membrane Anatomy 0.000 description 2
- 229940117916 cinnamic aldehyde Drugs 0.000 description 2
- KJPRLNWUNMBNBZ-UHFFFAOYSA-N cinnamic aldehyde Natural products O=CC=CC1=CC=CC=C1 KJPRLNWUNMBNBZ-UHFFFAOYSA-N 0.000 description 2
- 230000007547 defect Effects 0.000 description 2
- 230000008021 deposition Effects 0.000 description 2
- 235000019821 dicalcium diphosphate Nutrition 0.000 description 2
- 235000011180 diphosphates Nutrition 0.000 description 2
- XPPKVPWEQAFLFU-UHFFFAOYSA-N diphosphoric acid Chemical compound OP(O)(=O)OP(O)(O)=O XPPKVPWEQAFLFU-UHFFFAOYSA-N 0.000 description 2
- 231100000673 dose–response relationship Toxicity 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 239000010642 eucalyptus oil Substances 0.000 description 2
- 229940044949 eucalyptus oil Drugs 0.000 description 2
- 229960002217 eugenol Drugs 0.000 description 2
- 150000004673 fluoride salts Chemical class 0.000 description 2
- 239000006260 foam Substances 0.000 description 2
- 239000004088 foaming agent Substances 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 229960002737 fructose Drugs 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 210000004195 gingiva Anatomy 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- TVHALOSDPLTTSR-UHFFFAOYSA-H hexasodium;[oxido-[oxido(phosphonatooxy)phosphoryl]oxyphosphoryl] phosphate Chemical compound [Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[O-]P([O-])(=O)OP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O TVHALOSDPLTTSR-UHFFFAOYSA-H 0.000 description 2
- 235000019534 high fructose corn syrup Nutrition 0.000 description 2
- 229910052588 hydroxylapatite Inorganic materials 0.000 description 2
- 230000003993 interaction Effects 0.000 description 2
- 230000001788 irregular Effects 0.000 description 2
- CDOSHBSSFJOMGT-UHFFFAOYSA-N linalool Chemical compound CC(C)=CCCC(C)(O)C=C CDOSHBSSFJOMGT-UHFFFAOYSA-N 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 239000000594 mannitol Substances 0.000 description 2
- 235000010355 mannitol Nutrition 0.000 description 2
- 230000000873 masking effect Effects 0.000 description 2
- 210000004379 membrane Anatomy 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 238000001000 micrograph Methods 0.000 description 2
- RHFUXPCCELGMFC-UHFFFAOYSA-N n-(6-cyano-3-hydroxy-2,2-dimethyl-3,4-dihydrochromen-4-yl)-n-phenylmethoxyacetamide Chemical compound OC1C(C)(C)OC2=CC=C(C#N)C=C2C1N(C(=O)C)OCC1=CC=CC=C1 RHFUXPCCELGMFC-UHFFFAOYSA-N 0.000 description 2
- 230000003472 neutralizing effect Effects 0.000 description 2
- ZVVSSOQAYNYNPP-UHFFFAOYSA-N olaflur Chemical compound F.F.CCCCCCCCCCCCCCCCCCN(CCO)CCCN(CCO)CCO ZVVSSOQAYNYNPP-UHFFFAOYSA-N 0.000 description 2
- 229960001245 olaflur Drugs 0.000 description 2
- XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 description 2
- 201000001245 periodontitis Diseases 0.000 description 2
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 2
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 2
- NROKBHXJSPEDAR-UHFFFAOYSA-M potassium fluoride Chemical compound [F-].[K+] NROKBHXJSPEDAR-UHFFFAOYSA-M 0.000 description 2
- 230000003449 preventive effect Effects 0.000 description 2
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 238000007789 sealing Methods 0.000 description 2
- 210000000582 semen Anatomy 0.000 description 2
- 235000017557 sodium bicarbonate Nutrition 0.000 description 2
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 2
- PUZPDOWCWNUUKD-UHFFFAOYSA-M sodium fluoride Chemical compound [F-].[Na+] PUZPDOWCWNUUKD-UHFFFAOYSA-M 0.000 description 2
- 229960004711 sodium monofluorophosphate Drugs 0.000 description 2
- 239000001488 sodium phosphate Substances 0.000 description 2
- 235000011008 sodium phosphates Nutrition 0.000 description 2
- 235000019832 sodium triphosphate Nutrition 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 239000000600 sorbitol Substances 0.000 description 2
- 235000010356 sorbitol Nutrition 0.000 description 2
- 238000005728 strengthening Methods 0.000 description 2
- BDHFUVZGWQCTTF-UHFFFAOYSA-M sulfonate Chemical compound [O-]S(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-M 0.000 description 2
- MGSRCZKZVOBKFT-UHFFFAOYSA-N thymol Chemical compound CC(C)C1=CC=C(C)C=C1O MGSRCZKZVOBKFT-UHFFFAOYSA-N 0.000 description 2
- 229940095688 toothpaste product Drugs 0.000 description 2
- 230000000699 topical effect Effects 0.000 description 2
- RUVINXPYWBROJD-ONEGZZNKSA-N trans-anethole Chemical compound COC1=CC=C(\C=C\C)C=C1 RUVINXPYWBROJD-ONEGZZNKSA-N 0.000 description 2
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical class [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 150000003722 vitamin derivatives Chemical class 0.000 description 2
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 1
- AOFUBOWZWQFQJU-SNOJBQEQSA-N (2r,3s,4s,5r)-2,5-bis(hydroxymethyl)oxolane-2,3,4-triol;(2s,3r,4s,5s,6r)-6-(hydroxymethyl)oxane-2,3,4,5-tetrol Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O.OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@@H]1O AOFUBOWZWQFQJU-SNOJBQEQSA-N 0.000 description 1
- 239000001490 (3R)-3,7-dimethylocta-1,6-dien-3-ol Substances 0.000 description 1
- 239000001605 (5-methyl-2-propan-2-ylcyclohexyl) acetate Substances 0.000 description 1
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 description 1
- PHIQHXFUZVPYII-ZCFIWIBFSA-N (R)-carnitine Chemical compound C[N+](C)(C)C[C@H](O)CC([O-])=O PHIQHXFUZVPYII-ZCFIWIBFSA-N 0.000 description 1
- CDOSHBSSFJOMGT-JTQLQIEISA-N (R)-linalool Natural products CC(C)=CCC[C@@](C)(O)C=C CDOSHBSSFJOMGT-JTQLQIEISA-N 0.000 description 1
- ZIRURAJAJIQZFG-UHFFFAOYSA-N 1-aminopropane-1-sulfonic acid Chemical compound CCC(N)S(O)(=O)=O ZIRURAJAJIQZFG-UHFFFAOYSA-N 0.000 description 1
- MOEFFSWKSMRFRQ-UHFFFAOYSA-N 2-ethoxyphenol Chemical compound CCOC1=CC=CC=C1O MOEFFSWKSMRFRQ-UHFFFAOYSA-N 0.000 description 1
- JJJOZVFVARQUJV-UHFFFAOYSA-N 2-ethylhexylphosphonic acid Chemical compound CCCCC(CC)CP(O)(O)=O JJJOZVFVARQUJV-UHFFFAOYSA-N 0.000 description 1
- YKJZFNRWSLHRAG-UHFFFAOYSA-N 2-phosphanylacetic acid Chemical compound OC(=O)CP YKJZFNRWSLHRAG-UHFFFAOYSA-N 0.000 description 1
- HVCOBJNICQPDBP-UHFFFAOYSA-N 3-[3-[3,5-dihydroxy-6-methyl-4-(3,4,5-trihydroxy-6-methyloxan-2-yl)oxyoxan-2-yl]oxydecanoyloxy]decanoic acid;hydrate Chemical compound O.OC1C(OC(CC(=O)OC(CCCCCCC)CC(O)=O)CCCCCCC)OC(C)C(O)C1OC1C(O)C(O)C(O)C(C)O1 HVCOBJNICQPDBP-UHFFFAOYSA-N 0.000 description 1
- IRLPACMLTUPBCL-KQYNXXCUSA-N 5'-adenylyl sulfate Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(=O)OS(O)(=O)=O)[C@@H](O)[C@H]1O IRLPACMLTUPBCL-KQYNXXCUSA-N 0.000 description 1
- DDFHBQSCUXNBSA-UHFFFAOYSA-N 5-(5-carboxythiophen-2-yl)thiophene-2-carboxylic acid Chemical compound S1C(C(=O)O)=CC=C1C1=CC=C(C(O)=O)S1 DDFHBQSCUXNBSA-UHFFFAOYSA-N 0.000 description 1
- OZJPLYNZGCXSJM-UHFFFAOYSA-N 5-valerolactone Chemical compound O=C1CCCCO1 OZJPLYNZGCXSJM-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- DHHFDKNIEVKVKS-FMOSSLLZSA-N Betanin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC(C(=C1)O)=CC(C[C@H]2C([O-])=O)=C1[N+]2=C\C=C\1C=C(C(O)=O)N[C@H](C(O)=O)C/1 DHHFDKNIEVKVKS-FMOSSLLZSA-N 0.000 description 1
- DHHFDKNIEVKVKS-MVUYWVKGSA-N Betanin Natural products O=C(O)[C@@H]1NC(C(=O)O)=C/C(=C\C=[N+]/2\[C@@H](C(=O)[O-])Cc3c\2cc(O)c(O[C@H]2[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O2)c3)/C1 DHHFDKNIEVKVKS-MVUYWVKGSA-N 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 1
- XNRPSTJYNNPDAQ-UHFFFAOYSA-N CC.OC(C(CCCC)P(O)(O)=O)(CC)CC Chemical compound CC.OC(C(CCCC)P(O)(O)=O)(CC)CC XNRPSTJYNNPDAQ-UHFFFAOYSA-N 0.000 description 1
- USJRRHRBLNFFBW-UHFFFAOYSA-N CCC(CP(O)(O)=O)(CCCC)CC.N1CCCCCC1 Chemical compound CCC(CP(O)(O)=O)(CCCC)CC.N1CCCCCC1 USJRRHRBLNFFBW-UHFFFAOYSA-N 0.000 description 1
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 description 1
- KXDHJXZQYSOELW-UHFFFAOYSA-N Carbamic acid Chemical class NC(O)=O KXDHJXZQYSOELW-UHFFFAOYSA-N 0.000 description 1
- GHXZTYHSJHQHIJ-UHFFFAOYSA-N Chlorhexidine Chemical compound C=1C=C(Cl)C=CC=1NC(N)=NC(N)=NCCCCCCN=C(N)N=C(N)NC1=CC=C(Cl)C=C1 GHXZTYHSJHQHIJ-UHFFFAOYSA-N 0.000 description 1
- 235000007716 Citrus aurantium Nutrition 0.000 description 1
- 240000003791 Citrus myrtifolia Species 0.000 description 1
- 235000000228 Citrus myrtifolia Nutrition 0.000 description 1
- 235000016646 Citrus taiwanica Nutrition 0.000 description 1
- 241000675108 Citrus tangerina Species 0.000 description 1
- 229920002261 Corn starch Polymers 0.000 description 1
- 240000008067 Cucumis sativus Species 0.000 description 1
- 235000010799 Cucumis sativus var sativus Nutrition 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 1
- XHXUANMFYXWVNG-UHFFFAOYSA-N D-menthyl acetate Natural products CC(C)C1CCC(C)CC1OC(C)=O XHXUANMFYXWVNG-UHFFFAOYSA-N 0.000 description 1
- HMFHBZSHGGEWLO-SOOFDHNKSA-N D-ribofuranose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H]1O HMFHBZSHGGEWLO-SOOFDHNKSA-N 0.000 description 1
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 108010016626 Dipeptides Proteins 0.000 description 1
- VUNOFAIHSALQQH-UHFFFAOYSA-N Ethyl menthane carboxamide Chemical compound CCNC(=O)C1CC(C)CCC1C(C)C VUNOFAIHSALQQH-UHFFFAOYSA-N 0.000 description 1
- 244000166124 Eucalyptus globulus Species 0.000 description 1
- GLWQRIMWMLJRIB-UHFFFAOYSA-N F.F.CCO Chemical compound F.F.CCO GLWQRIMWMLJRIB-UHFFFAOYSA-N 0.000 description 1
- 241000628997 Flos Species 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 229930186217 Glycolipid Natural products 0.000 description 1
- 102000003886 Glycoproteins Human genes 0.000 description 1
- 108090000288 Glycoproteins Proteins 0.000 description 1
- 229920001908 Hydrogenated starch hydrolysate Polymers 0.000 description 1
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 1
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 244000147568 Laurus nobilis Species 0.000 description 1
- 235000017858 Laurus nobilis Nutrition 0.000 description 1
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 1
- 102000012750 Membrane Glycoproteins Human genes 0.000 description 1
- 108010090054 Membrane Glycoproteins Proteins 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- CERQOIWHTDAKMF-UHFFFAOYSA-M Methacrylate Chemical compound CC(=C)C([O-])=O CERQOIWHTDAKMF-UHFFFAOYSA-M 0.000 description 1
- 241001136616 Methone Species 0.000 description 1
- 102000014171 Milk Proteins Human genes 0.000 description 1
- 108010011756 Milk Proteins Proteins 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- 239000004384 Neotame Substances 0.000 description 1
- 235000011203 Origanum Nutrition 0.000 description 1
- 241001529744 Origanum Species 0.000 description 1
- 244000046052 Phaseolus vulgaris Species 0.000 description 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
- 229920002260 Pluraflo® Polymers 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 108010009736 Protein Hydrolysates Proteins 0.000 description 1
- PYMYPHUHKUWMLA-LMVFSUKVSA-N Ribose Natural products OC[C@@H](O)[C@@H](O)[C@@H](O)C=O PYMYPHUHKUWMLA-LMVFSUKVSA-N 0.000 description 1
- 244000295490 Salvia japonica Species 0.000 description 1
- 235000005794 Salvia japonica Nutrition 0.000 description 1
- 102000007365 Sialoglycoproteins Human genes 0.000 description 1
- 108010032838 Sialoglycoproteins Proteins 0.000 description 1
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 239000004376 Sucralose Substances 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 235000005212 Terminalia tomentosa Nutrition 0.000 description 1
- 244000299461 Theobroma cacao Species 0.000 description 1
- 235000009470 Theobroma cacao Nutrition 0.000 description 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
- 239000004473 Threonine Substances 0.000 description 1
- 239000005844 Thymol Substances 0.000 description 1
- 206010044029 Tooth deposit Diseases 0.000 description 1
- XEFQLINVKFYRCS-UHFFFAOYSA-N Triclosan Chemical compound OC1=CC(Cl)=CC=C1OC1=CC=C(Cl)C=C1Cl XEFQLINVKFYRCS-UHFFFAOYSA-N 0.000 description 1
- 229930003451 Vitamin B1 Natural products 0.000 description 1
- 229930003779 Vitamin B12 Natural products 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 229930003316 Vitamin D Natural products 0.000 description 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
- 235000009392 Vitis Nutrition 0.000 description 1
- 241000219095 Vitis Species 0.000 description 1
- 208000005946 Xerostomia Diseases 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- UJNOLBSYLSYIBM-WISYIIOYSA-N [(1r,2s,5r)-5-methyl-2-propan-2-ylcyclohexyl] (2r)-2-hydroxypropanoate Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@H]1OC(=O)[C@@H](C)O UJNOLBSYLSYIBM-WISYIIOYSA-N 0.000 description 1
- WDQMJZCWOJDTLM-UHFFFAOYSA-N [Ca].NC(=N)N Chemical compound [Ca].NC(=N)N WDQMJZCWOJDTLM-UHFFFAOYSA-N 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid group Chemical group C(C=C)(=O)O NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- 239000011149 active material Substances 0.000 description 1
- 230000003044 adaptive effect Effects 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- 229910001515 alkali metal fluoride Inorganic materials 0.000 description 1
- HMFHBZSHGGEWLO-UHFFFAOYSA-N alpha-D-Furanose-Ribose Natural products OCC1OC(O)C(O)C1O HMFHBZSHGGEWLO-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 description 1
- UZFLPKAIBPNNCA-BQYQJAHWSA-N alpha-ionone Chemical compound CC(=O)\C=C\C1C(C)=CCCC1(C)C UZFLPKAIBPNNCA-BQYQJAHWSA-N 0.000 description 1
- UZFLPKAIBPNNCA-UHFFFAOYSA-N alpha-ionone Natural products CC(=O)C=CC1C(C)=CCCC1(C)C UZFLPKAIBPNNCA-UHFFFAOYSA-N 0.000 description 1
- WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 description 1
- 229910021502 aluminium hydroxide Inorganic materials 0.000 description 1
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
- SMYKVLBUSSNXMV-UHFFFAOYSA-K aluminum;trihydroxide;hydrate Chemical compound O.[OH-].[OH-].[OH-].[Al+3] SMYKVLBUSSNXMV-UHFFFAOYSA-K 0.000 description 1
- 150000003863 ammonium salts Chemical class 0.000 description 1
- 239000002280 amphoteric surfactant Substances 0.000 description 1
- 229940011037 anethole Drugs 0.000 description 1
- 150000001450 anions Chemical class 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 229910052586 apatite Inorganic materials 0.000 description 1
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 229940024526 arginine / calcium carbonate Drugs 0.000 description 1
- 230000008953 bacterial degradation Effects 0.000 description 1
- 230000037358 bacterial metabolism Effects 0.000 description 1
- 239000001654 beetroot red Substances 0.000 description 1
- 235000012677 beetroot red Nutrition 0.000 description 1
- FFBHFFJDDLITSX-UHFFFAOYSA-N benzyl N-[2-hydroxy-4-(3-oxomorpholin-4-yl)phenyl]carbamate Chemical compound OC1=C(NC(=O)OCC2=CC=CC=C2)C=CC(=C1)N1CCOCC1=O FFBHFFJDDLITSX-UHFFFAOYSA-N 0.000 description 1
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 1
- 235000002185 betanin Nutrition 0.000 description 1
- 229940093797 bioflavonoids Drugs 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- FAPWYRCQGJNNSJ-UBKPKTQASA-L calcium D-pantothenic acid Chemical compound [Ca+2].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O.OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O FAPWYRCQGJNNSJ-UBKPKTQASA-L 0.000 description 1
- 229940043430 calcium compound Drugs 0.000 description 1
- 150000001674 calcium compounds Chemical class 0.000 description 1
- AXCZMVOFGPJBDE-UHFFFAOYSA-L calcium dihydroxide Chemical compound [OH-].[OH-].[Ca+2] AXCZMVOFGPJBDE-UHFFFAOYSA-L 0.000 description 1
- 239000000920 calcium hydroxide Substances 0.000 description 1
- 229910001861 calcium hydroxide Inorganic materials 0.000 description 1
- 229910001424 calcium ion Inorganic materials 0.000 description 1
- 229960002079 calcium pantothenate Drugs 0.000 description 1
- RZGYKJLLLHOTLC-UHFFFAOYSA-L calcium;carbonic acid;dihydrogen phosphate;fluoride Chemical compound [F-].[Ca+2].OC(O)=O.OP(O)([O-])=O RZGYKJLLLHOTLC-UHFFFAOYSA-L 0.000 description 1
- 229940025250 camphora Drugs 0.000 description 1
- 239000010238 camphora Substances 0.000 description 1
- 230000023852 carbohydrate metabolic process Effects 0.000 description 1
- 235000021256 carbohydrate metabolism Nutrition 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- NKCVNYJQLIWBHK-UHFFFAOYSA-N carbonodiperoxoic acid Chemical compound OOC(=O)OO NKCVNYJQLIWBHK-UHFFFAOYSA-N 0.000 description 1
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 125000002091 cationic group Chemical group 0.000 description 1
- 230000030833 cell death Effects 0.000 description 1
- 210000002421 cell wall Anatomy 0.000 description 1
- 239000004568 cement Substances 0.000 description 1
- 229960001927 cetylpyridinium chloride Drugs 0.000 description 1
- YMKDRGPMQRFJGP-UHFFFAOYSA-M cetylpyridinium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCC[N+]1=CC=CC=C1 YMKDRGPMQRFJGP-UHFFFAOYSA-M 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- AGVAZMGAQJOSFJ-WZHZPDAFSA-M cobalt(2+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+2].N#[C-].[N-]([C@@H]1[C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP(O)(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O AGVAZMGAQJOSFJ-WZHZPDAFSA-M 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 239000008120 corn starch Substances 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- HCAJEUSONLESMK-UHFFFAOYSA-N cyclohexylsulfamic acid Chemical class OS(=O)(=O)NC1CCCCC1 HCAJEUSONLESMK-UHFFFAOYSA-N 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- 239000003479 dental cement Substances 0.000 description 1
- 210000003074 dental pulp Anatomy 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 239000008121 dextrose Substances 0.000 description 1
- QGGZBXOADPVUPN-UHFFFAOYSA-N dihydrochalcone Chemical compound C=1C=CC=CC=1C(=O)CCC1=CC=CC=C1 QGGZBXOADPVUPN-UHFFFAOYSA-N 0.000 description 1
- PXLWOFBAEVGBOA-UHFFFAOYSA-N dihydrochalcone Natural products OC1C(O)C(O)C(CO)OC1C1=C(O)C=CC(C(=O)CC(O)C=2C=CC(O)=CC=2)=C1O PXLWOFBAEVGBOA-UHFFFAOYSA-N 0.000 description 1
- BADXJIPKFRBFOT-UHFFFAOYSA-N dimedone Chemical compound CC1(C)CC(=O)CC(=O)C1 BADXJIPKFRBFOT-UHFFFAOYSA-N 0.000 description 1
- XPPKVPWEQAFLFU-UHFFFAOYSA-J diphosphate(4-) Chemical compound [O-]P([O-])(=O)OP([O-])([O-])=O XPPKVPWEQAFLFU-UHFFFAOYSA-J 0.000 description 1
- 235000019820 disodium diphosphate Nutrition 0.000 description 1
- GYQBBRRVRKFJRG-UHFFFAOYSA-L disodium pyrophosphate Chemical compound [Na+].[Na+].OP([O-])(=O)OP(O)([O-])=O GYQBBRRVRKFJRG-UHFFFAOYSA-L 0.000 description 1
- 229940038485 disodium pyrophosphate Drugs 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 239000008298 dragée Substances 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 206010013781 dry mouth Diseases 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000009881 electrostatic interaction Effects 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 230000003628 erosive effect Effects 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 150000002222 fluorine compounds Chemical class 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- UPBDXRPQPOWRKR-UHFFFAOYSA-N furan-2,5-dione;methoxyethene Chemical compound COC=C.O=C1OC(=O)C=C1 UPBDXRPQPOWRKR-UHFFFAOYSA-N 0.000 description 1
- 229930182830 galactose Natural products 0.000 description 1
- 229960003082 galactose Drugs 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 150000002357 guanidines Chemical class 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 229940071826 hydroxyethyl cellulose Drugs 0.000 description 1
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 1
- 230000028993 immune response Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 229910052738 indium Inorganic materials 0.000 description 1
- APFVFJFRJDLVQX-UHFFFAOYSA-N indium atom Chemical compound [In] APFVFJFRJDLVQX-UHFFFAOYSA-N 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 229910052816 inorganic phosphate Inorganic materials 0.000 description 1
- 230000002427 irreversible effect Effects 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 238000002386 leaching Methods 0.000 description 1
- 229960001518 levocarnitine Drugs 0.000 description 1
- 229930007744 linalool Natural products 0.000 description 1
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 1
- 235000020778 linoleic acid Nutrition 0.000 description 1
- 230000003212 lipotrophic effect Effects 0.000 description 1
- 230000004807 localization Effects 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 229940041616 menthol Drugs 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 229960001047 methyl salicylate Drugs 0.000 description 1
- 235000021239 milk protein Nutrition 0.000 description 1
- 239000003607 modifier Substances 0.000 description 1
- 210000002200 mouth mucosa Anatomy 0.000 description 1
- 239000002324 mouth wash Substances 0.000 description 1
- 229940051866 mouthwash Drugs 0.000 description 1
- HLIAVLHNDJUHFG-HOTGVXAUSA-N neotame Chemical compound CC(C)(C)CCN[C@@H](CC(O)=O)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 HLIAVLHNDJUHFG-HOTGVXAUSA-N 0.000 description 1
- 235000019412 neotame Nutrition 0.000 description 1
- 108010070257 neotame Proteins 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- 235000008935 nutritious Nutrition 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 239000003002 pH adjusting agent Substances 0.000 description 1
- 239000006174 pH buffer Substances 0.000 description 1
- QNGNSVIICDLXHT-UHFFFAOYSA-N para-ethylbenzaldehyde Natural products CCC1=CC=C(C=O)C=C1 QNGNSVIICDLXHT-UHFFFAOYSA-N 0.000 description 1
- RUVINXPYWBROJD-UHFFFAOYSA-N para-methoxyphenyl Natural products COC1=CC=C(C=CC)C=C1 RUVINXPYWBROJD-UHFFFAOYSA-N 0.000 description 1
- 239000010663 parsley oil Substances 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- VSIIXMUUUJUKCM-UHFFFAOYSA-D pentacalcium;fluoride;triphosphate Chemical compound [F-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O VSIIXMUUUJUKCM-UHFFFAOYSA-D 0.000 description 1
- 125000002467 phosphate group Chemical group [H]OP(=O)(O[H])O[*] 0.000 description 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 231100000572 poisoning Toxicity 0.000 description 1
- 230000000607 poisoning effect Effects 0.000 description 1
- 238000005498 polishing Methods 0.000 description 1
- 229920000098 polyolefin Polymers 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 239000011698 potassium fluoride Substances 0.000 description 1
- 235000003270 potassium fluoride Nutrition 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 description 1
- 229940048084 pyrophosphate Drugs 0.000 description 1
- 229940005657 pyrophosphoric acid Drugs 0.000 description 1
- 238000012797 qualification Methods 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 235000019192 riboflavin Nutrition 0.000 description 1
- 239000002151 riboflavin Substances 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 235000019615 sensations Nutrition 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 230000001953 sensory effect Effects 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002028 silica xerogel Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000002002 slurry Substances 0.000 description 1
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 1
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 1
- FQENQNTWSFEDLI-UHFFFAOYSA-J sodium diphosphate Chemical compound [Na+].[Na+].[Na+].[Na+].[O-]P([O-])(=O)OP([O-])([O-])=O FQENQNTWSFEDLI-UHFFFAOYSA-J 0.000 description 1
- 239000011775 sodium fluoride Substances 0.000 description 1
- 235000013024 sodium fluoride Nutrition 0.000 description 1
- GCLGEJMYGQKIIW-UHFFFAOYSA-H sodium hexametaphosphate Chemical compound [Na]OP1(=O)OP(=O)(O[Na])OP(=O)(O[Na])OP(=O)(O[Na])OP(=O)(O[Na])OP(=O)(O[Na])O1 GCLGEJMYGQKIIW-UHFFFAOYSA-H 0.000 description 1
- 235000019982 sodium hexametaphosphate Nutrition 0.000 description 1
- 229910000162 sodium phosphate Inorganic materials 0.000 description 1
- UGTZMIPZNRIWHX-UHFFFAOYSA-K sodium trimetaphosphate Chemical compound [Na+].[Na+].[Na+].[O-]P1(=O)OP([O-])(=O)OP([O-])(=O)O1 UGTZMIPZNRIWHX-UHFFFAOYSA-K 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000006104 solid solution Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 235000013599 spices Nutrition 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- ANOBYBYXJXCGBS-UHFFFAOYSA-L stannous fluoride Chemical compound F[Sn]F ANOBYBYXJXCGBS-UHFFFAOYSA-L 0.000 description 1
- 229960002799 stannous fluoride Drugs 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 239000000021 stimulant Substances 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 235000019408 sucralose Nutrition 0.000 description 1
- BAQAVOSOZGMPRM-QBMZZYIRSA-N sucralose Chemical compound O[C@@H]1[C@@H](O)[C@@H](Cl)[C@@H](CO)O[C@@H]1O[C@@]1(CCl)[C@@H](O)[C@H](O)[C@@H](CCl)O1 BAQAVOSOZGMPRM-QBMZZYIRSA-N 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 150000003871 sulfonates Chemical class 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 235000019818 tetrasodium diphosphate Nutrition 0.000 description 1
- 239000001577 tetrasodium phosphonato phosphate Substances 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- KYMBYSLLVAOCFI-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SCN1CC1=CN=C(C)N=C1N KYMBYSLLVAOCFI-UHFFFAOYSA-N 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 229960000790 thymol Drugs 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 229960003500 triclosan Drugs 0.000 description 1
- 235000012141 vanillin Nutrition 0.000 description 1
- MWOOGOJBHIARFG-UHFFFAOYSA-N vanillin Chemical compound COC1=CC(C=O)=CC=C1O MWOOGOJBHIARFG-UHFFFAOYSA-N 0.000 description 1
- FGQOOHJZONJGDT-UHFFFAOYSA-N vanillin Natural products COC1=CC(O)=CC(C=O)=C1 FGQOOHJZONJGDT-UHFFFAOYSA-N 0.000 description 1
- 235000010374 vitamin B1 Nutrition 0.000 description 1
- 239000011691 vitamin B1 Substances 0.000 description 1
- 235000019163 vitamin B12 Nutrition 0.000 description 1
- 239000011715 vitamin B12 Substances 0.000 description 1
- 235000019158 vitamin B6 Nutrition 0.000 description 1
- 239000011726 vitamin B6 Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
- 239000011710 vitamin D Substances 0.000 description 1
- 150000003710 vitamin D derivatives Chemical class 0.000 description 1
- 229940011671 vitamin b6 Drugs 0.000 description 1
- 239000009637 wintergreen oil Substances 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
- LRXTYHSAJDENHV-UHFFFAOYSA-H zinc phosphate Chemical compound [Zn+2].[Zn+2].[Zn+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O LRXTYHSAJDENHV-UHFFFAOYSA-H 0.000 description 1
- 239000002888 zwitterionic surfactant Substances 0.000 description 1
Landscapes
- Cosmetics (AREA)
Abstract
The invention relates to an oral cavity composition containing polyguanidine compounds and a preparation and application method of oral cavity composition. Modification of a material based on polyamine is described so as to form the polyguanidine compounds of which the antimicrobial, tooth decay prevention and mucus adhesive properties can be utilized. The invention further relates to a method for preventing or treating a periodontal disease and decayed teeth. The method comprises the step of delivering treatment effective dose of the oral cavity composition containing the polyguanidine compounds to an oral cavity.
Description
The application is the applying date is on May 18th, 2009, and application number is 200980159445.1 (international application no is PCT/US2009/044349), and denomination of invention is " containing poly-guanidine
the oral cavity composition of compound and preparation and application thereof " the divisional application of application for a patent for invention.
Invention field
The present invention includes the oral care composition being included in the polyguanidine compound distributed in the acceptable carrier of oral cavity.The present invention also comprises method for the preparation of the oral cavity composition containing polyguanidine compound and using method thereof.The present invention also comprises makes active component targeting oral epithelium tissue, deposit antibacterial material or sterilization material on an oral surface, postpone or prophylaxis of teeth dental caries, treatment or prevention odontohyperesthesia, blocking dential canaliculi, treatment carious lesions, makes the pulp calcification of exposure, and making the method for the pit of tooth or the substrate in crack or whole calcifications etc., described method comprises the oral cavity composition comprising polyguanidine compound of delivery treatments effective dose in oral cavity.
Background of invention
Periodontal disease and dental caries are most popular dental problems.Except affecting oral cavity tissue, periodontal disease is also relevant to multiple general disease.The feature of gingivitis (mild forms of disease) is host tissue inflammation and the accumulation of the antibacterial dental plaque around gingival edge.Treating gingivitis by the oral hygiene practice improved can remarkable reverse disease situation.But leave not treat, gingivitis can cause more serious and irreversible periodontitis, periodontitis to comprise progressively losing periodontal alveolar bone, and leaves not treat, and tooth can be caused loose and lose subsequently.
Dental caries is the communicable odontopathy of most, and can cause enamel, dentine and cementum demineralization and loss.If do not treated, cause the antibacterial dental plaque of dental caries also can cause dentin hypersensitiveness and pain, and lose tooth subsequently.As the end product of the bacterial degradation of fermentable carbohydrate, acid dissolve hydroxyapatite, this hydroxyapatite is the calcium phosphate mineral forming enamel, dentine and cemental most of mineral.Acidizer (comprising some food and oral cavity personal care product) also can cause tooth demineralisation.In the latter, many is commercially available collutory and grinding toothpaste.
Summary of the invention
The present invention includes the compositions of the material comprised based on polyamine, the described material based on polyamine forms the polyguanidine compound that can utilize their antimicrobial, preventing decayed tooth and mucus bond property.Therefore, the present invention includes polyguanidine compound, described polyguanidine compound comprises the active component had with character in antimicrobial and acid, with the antibacterial dental plaque that targeting is relevant with dental caries with the periodontal disease in such as oral cavity.
In one embodiment, the present invention includes a kind of oral cavity composition, described oral cavity composition contains the polyguanidine compound and oral cavity acceptable carrier that comprise gegenion.
In another embodiment, the present invention includes the method for the preparation of oral cavity composition, described oral cavity composition is included in the polyguanidine compound comprising gegenion distributed in the acceptable carrier of oral cavity.
In another embodiment, present invention resides in the method for anti-bacteria dental plaque in oral cavity, described method comprises to be made mammiferous oral epithelium tissue and/or tooth and comprises the compositions comprising the polyguanidine compound of gegenion for the treatment of effective dose and contact.
In another embodiment, the present invention includes the method for the prevention periodontal disease in oral cavity and dental caries morbidity, described method comprises to be made mammiferous oral epithelium tissue and/or tooth and comprises the compositions comprising the polyguanidine compound of gegenion for the treatment of effective dose and contact.
In another embodiment, present invention resides in the method for antibacterial material or the sterilization material retained after oral surfaces is deposited on brush or rinsing, described method comprises the oral cavity composition comprising the polyguanidine compound of gegenion sent in oral cavity and comprise treatment effective dose.
In another embodiment, the present invention includes delay or the method for prophylaxis of teeth dental caries, described method comprise in oral cavity delivery treatments effective dose containing the oral cavity composition of polyguanidine compound comprising gegenion.
In another embodiment, the present invention includes the method for the treatment of or prevention odontohyperesthesia, described method comprise in oral cavity delivery treatments effective dose containing the oral cavity composition of polyguanidine compound comprising gegenion.
In another embodiment, the present invention includes the method for inaccessible dential canaliculi, described method comprise in oral cavity delivery treatments effective dose containing the oral cavity composition of polyguanidine compound comprising gegenion.
In another embodiment, the present invention includes the method for the treatment of carious lesions, described method comprise in oral cavity delivery treatments effective dose containing the oral cavity composition of polyguanidine compound comprising gegenion.
In another embodiment, the present invention includes the method for the pulp calcification making exposure, described method comprise in oral cavity delivery treatments effective dose containing the oral cavity composition of polyguanidine compound comprising gegenion.
In another embodiment, the present invention includes the method making the pit of tooth or the substrate in crack or all calcifications, described method comprise in oral cavity delivery treatments effective dose containing the oral cavity composition of polyguanidine compound comprising gegenion.
Accompanying drawing is sketched
Fig. 1 illustrates a series of images using the inaccessible dential canaliculi of compositions disclosed herein.
Fig. 2 is the acid proof a series of images that dentin surface after by compositions-treated disclosed herein is described.
The figure of the comparison between the dentine electrical conductivity that Fig. 3 measures for explanation reference composition and compositions-treated disclosed herein.Line representative is above containing the sample of bioactivity glass, and line representative below contrasts.
Detailed Description Of The Invention
The present invention includes oral care composition comprising polyguanidine compound or its salt and oral cavity acceptable carrier and preparation method thereof.The present invention also comprises the method for preventing or treat periodontal disease and dental caries, and described method comprises the oral cavity composition sending the polyguanidine compound or its salt comprising treatment effective dose in oral cavity.
i. polyguanidine compositions
The present invention includes oral care composition, described oral care composition comprises the polyguanidine compound or its salt that at least one can utilize its antimicrobial, preventing decayed tooth and/or mucus bond property.Comprise polyguanidine compound in the present invention and salt can deposit therapeutic agent and gegenion on an oral surface, suppress the growth of long-time antibacterial class biology after using described compositions as antimicrobial, and keep the pH that raises and promote remineralization.In some embodiments, polyguanidine compositions of the present invention comprises: at least one polycation material, at least one gegenion class material and at least one oral cavity acceptable carrier.
A. poly-(guanidine of the present invention
) compound
The present invention includes and comprise at least one and gather guanidine
the oral cavity composition of compound.Term used herein " polyguanidine " or " poly-guanidine
" be used interchangeably and refer to the compound of formula (I):
Wherein
When Z is CH, R
1for hydrogen, hydroxide, methoxyl group compound and straight or branched, saturated or undersaturated optional hydroxylated C
1-c
16alkyl, or when Z is N, R
1for hydrogen and straight or branched, saturated or undersaturated optional hydroxylated C
1-C
16alkyl;
R
2and R
3be hydrogen or straight or branched, saturated or undersaturated optional hydroxylated C independently of one another
1-C
16alkyl;
A is covalent bond or straight or branched, saturated or undersaturated optional hydroxylated C
1-C
16alkyl;
Z is CH or N;
X
-for gegenion, such as, bicarbonate radical or chloride ion; With
N is between 2-5, the integer of 000.
Poly-guanidine of the present invention
the ion that compound can exist the acceptable band multi-charge in oral cavity maybe can dissociate the salt of the ion becoming band multi-charge, and it has clean positive charge.In some embodiments, described polycation material is polyamine.In some embodiments, described polycation material is poly-guanidine
compound.
In some embodiments, described polyguanidine compound comprises at least one side base (R
1).In some embodiments, described side base (R
1) be hydrogen; Hydroxyl; With straight or branched, saturated or undersaturated optional hydroxylated C
1-C
16alkyl.In one embodiment, described side base is hydrogen atom.
In some embodiments, described polyguanidine compound comprises carbohydrate chain (A).In some embodiments, described alkyl chain (A) be straight or branched, saturated or undersaturated optional hydroxylated C
1-C
16alkyl.In some embodiments, described alkyl chain (A) is comprised by least one straight or branched, the saturated or undersaturated C that following group optionally replaces
1-C
16alkylidene: hydroxyl, carboxyl, carboxylate group or halogen; The optional alkylidene being selected from following functional group containing at least one: amine, ether, thioether, ester, amide, carbamate, urea, by C
1-C
8the C that alkyl, hydroxyl or halogen optionally replace
6aryl or C
3-C
8ring.In some embodiments, described alkyl chain (A) is for one or more unsubstituted or by C
1-C
8the C of alkyl, hydroxyl or halogen substiuted
6or C
7aryl or C
5-C
7cycloalkyl ring.In some embodiments, described carbohydrate chain (A) is selected from: C
10-C
14polyaryl or C
6-C
10multi-ring alkyl chain, it can be selected from following functional group interval by least one: C
1-C
8alkylidene, amine, amide, ether, thioether, hydrogen atom, carbamate or urea.
In some embodiments, described polyguanidine compound comprises n unit, and wherein n represents between 2-5, the integer of 000.
In certain embodiments, described poly-guanidine
compound is:
In some embodiments, described polyguanidine compound has anti-microbial properties.In one embodiment, the antimicrobial acivity of polyguanidine compound is owing to there is strong basicity cationic structural, being similar to hibitane.Be not wishing to be bound by theory, the mechanism of this effect is due to positive charge, and this positive charge is attracted by force by the acidic-group occurred in sialoprotein.As a result, the pellicle of this positive charge in oral cavity and soft tissue are combined by force, this positive charge can stop exceedance hour wherein.Therefore, Ca needed for pellicle and gingiva is adhered to by adhering to electronegative bacteria wall and dividing antibacterial dental plaque subsequently
2+salt bridge, poly-guanidine
salt anti-bacteria grows in the oral cavity.In one embodiment, polyguanidine compound of the present invention is polycation, because they have common antimicrobial acivity to the affinity of electronegative bacteria cell wall.In one embodiment, the interaction of this opposite charges causes relevant with bacterial membrane and divides bacterial membrane, and anti-bacteria dental plaque can be caused to adhere to or bacterial cell death.
In some embodiments, poly-guanidine of the present invention
compound has mucus bond property.In some embodiments, these mucus bond properties comprise electrostatic and lipotropy interaction.Due to membrane glycoprotein and glycolipid, oral surfaces (comprising mucous epithelium) has net negative charge.Glycoprotein in saliva is also containing overall negative charge.In addition, oral surfaces contains and a large amount of is embedded in phosphate in cell membrane and the electrically charged class material of bidentate, and they can interact with polycation, to produce the strong binding agent lipophilic moieties that can cross cytolipin plasma membrane.Therefore, in one embodiment, poly-guanidine of the present invention
compound has strong affinity due to electrostatic interaction to oral mucosa surface.
In one embodiment, described poly-guanidine
compound is formed and bonds lipophilic moieties by force, and this lipophilic moieties can be attracted in oral cavity tissue.In one embodiment, described polyguanidine compound is by the relevant direct targeting oral surfaces of active component.In one embodiment, the absorption of described polyguanidine compound promoted active component in oral cavity tissue.In one embodiment, described active component is selected from antibacterial material and sterilization material.In one embodiment, described polyguanidine compound deposits antibacterial material or sterilization material on an oral surface, and these materials retain long-time after brush and rinsing.
B. gegenion
In some embodiments, oral care composition of the present invention comprises at least one gegenion class material.In some embodiments, the source of gegenion is selected from: antimicrobial, anti-caries agent and acid-neutralization compound.In some embodiments, oral cavity composition of the present invention combines and is selected from following gegenion: carbonate and phosphate radical.In some embodiments, described gegenion class material is carbonate.In some embodiments, described gegenion class material is bicarbonate radical.In some embodiments, described gegenion class material is phosphate radical.In some embodiments, described gegenion class material is chloride ion.
In one embodiment, described at least one gegenion class material is bicarbonate radical.In some embodiments, oral cavity composition of the present invention also comprises the second gegenion class material.In some embodiments, described second gegenion class material is carbonate.In one embodiment, described second gegenion class material is calcium carbonate.
In some embodiments, comprise can neutralizing acid and/or affect the gegenion class material of bacterial metabolism occurred on an oral surface for oral cavity composition of the present invention.In some embodiments, described gegenion class material can reduce demineralization.In some embodiments, described gegenion class material is phosphate radical, by providing surface murder by poisoning and the orthophosphate by being hydrolyzed to the solubilising being suppressed tooth enamel by mass action on tooth enamel, can reduce tooth demineralisation.
In some embodiments, described gegenion class material is for providing carbonate or the bicarbonate radical of cushioning effect, and this cushioning effect reduces the amount that can be used for the acid in dental plaque and on tooth surfaces of dissolving tooth mineral matter.In some embodiments, by keeping pH close to the optimum pH by Plaque bacteria degraded guanidine, described carbonate or bicarbonate radical gegenion class material strengthen the sour Neutralization effect of polyguanidine compound.By many antibacterials as the source of nitrogen-containing compound and metabolism guanidine.Guanidine ruptures, and causes producing ammonia as by-product, and ammonia also contributes to acid neutralization and keeps higher pH level.In some embodiments, described carbonate or bicarbonate radical gegenion class material keep the level of pH to pH6.0 to pH9.0.In one embodiment, the pH of described oral cavity composition is in pH7.0 to pH8.0 scope.In some embodiments, when acid is neutralized, described carbonate or bicarbonate radical gegenion class material reduce the concentration of carbon dioxide.
C. carrier
Acceptable oral carriers comprises the oral delivery systems of any routine, such as dental care products, food and chewing gum.The example of dental care products can include but not limited to the collutory of dentifrice, topical solutions or paste, liquid preparation or spray or slurry form, powder, gel or tablet and dental floss.The example that can contain the food of oral cavity composition as herein described includes but not limited to dragee and confection.
In some embodiments, oral cavity composition of the present invention can containing the composition for any routine of concrete oral carriers known to persons of ordinary skill in the art.Such as, liquid mouthwash can contain solvent, such as distilled water or deionized water, ethanol etc.; Sweeting agent, such as glucide, aspartame etc.; And correctives, such as Oleum menthae, Herba Menthae Rotundifoliae wet goods.Dentifrice paste or gel can contain such as water, glycerol or Sorbitol; Conventional grinding agent, such as calcium pyrophosphate, aluminium hydroxide, resin, insoluble alkali metal metaphosphate etc.; Binding agent, such as hydroxyethyl-cellulose, xanthan gum, sodium carboxymethyl cellulose etc.; Foaming agent, such as sodium lauryl sulphate, sodium cocoglyceryl one acid esters sodium sulfonate, N-methyl-N-palmityl taurine sodium etc.; Correctives; Sweeting agent; Antiseptic and any other composition needed for concrete preparation.Dentifrice powder can containing conventional grinding agent and correctives.Tablet and powder can contain such as vehicle, such as lactose, mannitol etc.; Binding agent, such as corn starch, carboxymethyl cellulose etc.; And disintegrating agent.
Can be better simply compositions for topical application to the dentifrice of sensitive teeth position (the breech cementum of root surface that such as oral cavity exposes) or paste, and use with soft applicator.Such dentifrice or paste can contain or can be free of conventional grinding agent, foaming agent and correctives.Localization position (such as, for Dental Erosion, making the dentine after tooth) also relate to better simply compositions, and comprise for any other composition needed for the filler of dental pulp shutoff, cavity lining and cement and compositions well known by persons skilled in the art.Such as, zinc oxide and eugenol are applicable to tooth cements compositions.
D. excipient
In some embodiments, polyguanidine compositions of the present invention also can comprise at least one excipient.Described excipient is optional adaptive for any chemistry grouping of the present invention or the compound of classification.
In some embodiments, oral cavity composition of the present invention also comprises calcium salt.In some embodiments, described calcium salt is selected from: calcium carbonate, one-lime phosphate, dicalcium phosphate, tricalcium phosphate, calcium fluoride, MFP calcium, calcium pyrophosphate sodium, calcium laurate, calcium palmitate, and their combination.In one embodiment, described calcium salt is calcium carbonate.In some embodiments, described calcium salt produces calcium hydroxide, makes tooth enamel remineralization.In some embodiments, described calcium salt is calcium fluoride.In some embodiments, oral cavity composition of the present invention comprises the calcium fluoride for the treatment of effective dose.
In some embodiments, oral cavity composition of the present invention also comprises phosphorus source.In some embodiments, described phosphorus source is be selected from following phytate or phytic acid: inositoltriphosphoric acid salt (IP3), inositol tetrakisphosphate salt (IP4), IP5 salt (IP5), phytate (IP6), and their combination.These compounds contain multiple phosphate groups, and result can form ionic bridge with cation.
In some embodiments, the oral cavity composition of the present invention comprising polyguanidine compound and bicarbonate radical gegenion class material also comprises calcium carbonate and phytate.In some embodiments, comprise polyguanidine compound and bicarbonate radical gegenion class material, and the described oral cavity composition comprising calcium carbonate and phytate prevents pH from declining by the buffer capacity of bicarbonate radical and carbanion.Multiple bicarbonate radical gegenion can be carried in each chain of polyguanidine compound of the present invention, neutralize for acid.Guanidine
first the large pKa value of group can stablize bicarbonate radical gegenion class material.Bicarbonate and carbonate can neutralize this acidic by-products with the acidic by-products direct reaction from carbohydrate fermentation product produced by antibacterial dental plaque subsequently.The pH scope of this rising suppresses the formation of dental caries and facilitates remineralization by the existence of calcium ion.
In some embodiments, described polyguanidine compound, calcium carbonate and phytate also can interact, to form complex compound.In some embodiments, described polyguanidine compound and calcium carbonate can with phytate bonding, to form calcium guanidine phytic acid root complex.In some embodiments, by being used in Ca
2+and guanidine
form the phytate of ionic bridge between polycation, help of the present invention based on combining in the oral cavity composition of polyguanidine and sending Ca
2+ion.
iI. other compositions in the present compositions
In certain embodiments, the present invention can comprise the conventional any other additive for dentifrice formulation.Any suitable additive of any suitable amount or form can be used.Include but not limited to for suitable additive of the present invention: surfactant, desensitizer (comprising potassium salt), fluorine source, brightening agent, tartar control agents, antibacterial, grinding agent (comprising silicon dioxide), binding agent, thickening agent, detergent, adhesive agent, foam modifier, pH adjusting agent, taste agent, sweeting agent, correctives, coloring agent, antiseptic, their combination etc.It should be understood that these additives are optional component, and can individually or jointly be excluded in automatization of the present invention and wash dish compositions.Although it will also be appreciated that the universal performance of each in the material of above classification can be different, some common denominators can be there are, and in two or more in the material of these classifications, any given material can be used as multiple object.In certain embodiments, select other compositions of this kind of additive and bioactivity glass and compositions compatible.
A. surfactant
Be applicable to surfactant of the present invention include but not limited to: anion surfactant, non-ionic surface active agent, cationic surfactant, both sexes (amphoteric) surfactant, both sexes (ampholytic) surfactant, zwitterionic surfactant, with their mixture, as known to persons of ordinary skill in the art.Suitable surfactant can any suitable amount or form add, and optionally in surfactant system, and can add the character providing any expectation, includes but not limited to clean and/or foam properties.Suitable surfactant can comprise anion, cation, nonionic and amphoteric surfactant.
In one embodiment, compositions of the present invention comprises at least one surfactant.In one embodiment, the compositions comprising at least one surfactant comprises sodium lauryl sulphate.In one embodiment, compositions comprises the sodium lauryl sulphate that its amount is 0.5% weight-10% weight.In one embodiment, compositions comprises the sodium lauryl sulphate that its amount is 1% weight-5% weight.In one embodiment, compositions comprises the sodium lauryl sulphate that its amount is 1.5% weight-2% weight.
In one embodiment, the Dentrifice composition of the present invention comprising at least one surfactant comprises poloxamer.In one embodiment, the compositions comprising poloxamer comprises ethylene oxide/propylene oxide copolymer.In one embodiment, the compositions comprising poloxamer comprises the ethylene oxide/propylene oxide copolymer that its amount is 1.0% weight-45.0% weight.In one embodiment, the compositions comprising poloxamer comprises the ethylene oxide/propylene oxide copolymer that its amount is 5.0% weight-35.0% weight.In one embodiment, the compositions comprising poloxamer comprises the ethylene oxide/propylene oxide copolymer that its amount is 10.0% weight-25.0% weight.
B. tartar control agents
In some embodiments, compositions of the present invention optionally can comprise tartar and control (anti-dental calculus) agent, prepares the effect that this tartar control agents does not affect bioactivity glass detailed in this article and/or potassium salt.In herein useful those, tartar control agents comprises the salt of any one in these reagent following, such as their alkali metal salt and ammonium salt: phosphate and Quadrafos are (such as, pyrophosphate), poly-aminopropanesulfonic acid (AMPS), polyolefm sulfonates, polyolefin phosphates, diphosphate is azacycloparaffin-2 such as, 2-diphosphate (such as, azepan-2, 2-di 2 ethylhexyl phosphonic acid), N-methyl azacyclopentane-2, 3-di 2 ethylhexyl phosphonic acid, ethane-1-hydroxyl-1, 1-di 2 ethylhexyl phosphonic acid (EHDP), ethane-1-amino-1, 1-diphosphate and phosphino-alkanecarboxylic acid.Useful inorganic phosphate and Quadrafos comprise an alkali valency, bibasic and three alkali valency sodium phosphates, sodium tripolyphosphate, sodium tetrapolyphosphate, pyrophosphoric acid one sodium, disodium pyrophosphate, Sodium phosphate (Na3HP2O7), tetrasodium pyrophosphate, sodium trimetaphosphate, sodium hexameta phosphate, and their mixture.
C. fluoride sources
Be applicable to the reagent that fluoride sources of the present invention can comprise the acceptable granular fluoride ion in any oral cavity, prepare the effect that this reagent does not affect bioactivity glass, and this reagent such as can be used as anti-caries agent.Suitable fluorine source can include but not limited to: ionic fluorides, comprises alkali metal fluoride; Amine fluoride, such as olaflur (N '-octadecyltrimethylen-iamine-N, N, N '-three (2-ethanol)-dihydrofluoride); Stannous fluoride; Indium; With ion mono-fluor phosphate, comprise alkali metal mono-fluor phosphate such as potassium fluoride, sodium fluoride and ammonium fluoride and single fluorophosphoric acid potassium, sodium monofluorophosphate and single fluorophosphoric acid ammonium; With their mixture.
In one embodiment, Dentrifice composition of the present invention also comprises fluorine source.In one embodiment, compositions also comprises fluoride salt.In one embodiment, the compositions also comprising fluoride salt comprises sodium monofluorophosphate.In one embodiment, when fluoride sources is ion mono-fluor phosphate, optionally can add calcium glycerophosphate, show the activity that calcium glycerophosphate strengthens ion mono-fluor phosphate.In one embodiment, compositions can comprise the fluorine source provided between 100-3000ppm fluorion.In one embodiment, compositions can comprise the fluorine source provided between 500-2000ppm fluorion.
D. brightening agent
Be applicable to brightening agent of the present invention and can comprise the effective agent of any treatment being applicable to oral cavity.Suitable brightening agent includes but not limited to: titanium dioxide, hydrogen peroxide, sodium tripolyphosphate etc.In one embodiment, Dentrifice composition of the present invention also comprises brightening agent.In one embodiment, compositions of the present invention also comprises titanium dioxide.In one embodiment, suitable level titanium dioxide can be comprised.
E. grinding agent
Be applicable to grinding agent of the present invention and can comprise the acceptable granular grinding agent in any oral cavity, prepare this grinding agent not affect the effect of bioactivity glass.Can include but not limited to for suitable grinding agent of the present invention: silicon dioxide, zinc orthophosphate, sodium bicarbonate (sodium bicarbonate), plastic grain, aluminium oxide, hydrated alumina, calcium carbonate, calcium pyrophosphate, and their mixture.Described silica abrasive can be natural amorphous silica, comprises kieselguhr; Or the amorphous silica of synthesis, such as precipitated silica; Or silica gel, such as silica xerogel; Or their mixture.
Usually, the amount being applicable to the grinding agent of Dentrifice composition of the present invention is experimentally determined, according to technology well known in the art, to provide the clean of acceptable level and polishing.In one embodiment, Dentrifice composition of the present invention comprises grinding agent.In one embodiment, compositions comprises silica abrasive.In one embodiment, silica abrasive exists with the amount of 1% weight-30% weight.In one embodiment, silica abrasive exists with the amount of 5% weight-15% weight.In one embodiment, silica abrasive exists with the amount of 7% weight-10% weight.
F. taste agent
Be applicable to give between operating period that taste agent of the present invention can be included in Dentrifice composition the quality of expectation or any form of other sensations or the acceptable material in any oral cavity of amount.Suitable taste agent can include but not limited to: the correctives, sweeting agent, saliva-stimulant etc. of dispersion.
Useful correctives comprises any material of the taste that can be used for enhancing composition or the mixture of material herein.The acceptable correctives that is natural or synthesis in any oral cavity can be used, such as taste masking oil, taste masking aldehyde, ester, alcohol, similar material, and their combination.Correctives comprises vanillin, Salvia japonica Thunb., origanum, parsley oil, Oleum Menthae Rotundifoliae, Oleum Cinnamomi, wintergreen oil (methyl salicylate), Oleum menthae, Oleum Caryophylli, laurel fat, Oleum Anisi Stellati, Eucalyptus oil, tangerine oil, fruit oil and essence, comprise derived from following those: Fructus Citri Limoniae, Fructus Citri tangerinae, Citrus aurantium Linn., Fructus Citri grandis, Fructus Pruni, Fructus Musae, Fructus Vitis viniferae, Fructus Mali pumilae, Fructus Fragariae Ananssae, Fructus Pruni pseudocerasi, Fructus Ananadis comosi etc., the spice derived by bean or pea and nut, such as coffee, cocoa powder, laughable class, Semen arachidis hypogaeae, Semen Armeniacae Amarum etc., absorption and the correctives encapsulated, and their mixture.Correctives is also included in mouth the composition providing fragrance and/or other sensory effects herein, comprises effect that is nice and cool or that heat.Such composition comprises menthol, menthyl acetate, menthyl lactate, Camphora, Eucalyptus oil, Eucalyptus alcohol, anethole, eugenol, Cortex cinnamomi japonici (Ramulus Cinnamomi), oxanone, α-ionone, acrylic guaiethol, thymol, linalool, benzaldehyde, cinnamic aldehyde, WS-3, N, 2,3-trimethyl-2-butanamide, 3-1-alkoxypropan in the Meng-1,2-glycol, cinnamic aldehyde glycerine acetal (CGA), methone glycerine acetal (MGA), and their mixture.One or more correctivess optionally exist with the total amount of 0.01%-5%, in multiple embodiments, optionally exist with the total amount of 0.05-2%, 0.1%-2.5% and 0.1-0.5%.
Useful sweeting agent comprises acceptable natural or artificial, the nutritious or apotrophic sweeting agent in oral cavity herein.Such sweeting agent comprises dextrose, dextrosan, sucrose, maltose, dextrin, dry Nulomoline, mannose, xylose, ribose, fructose, levulose, galactose, corn syrup (comprising high-fructose corn syrup and corn-syrup solids), the starch of partial hydrolysis, hydrogenated starch hydrolysates, Sorbitol, mannitol, xylitol, maltose alcohol, dextrinose, aspartame, neotame, glucide and salt thereof, sucralose, based on the intense sweetness agent of dipeptides, ring is sulfonate (cyclamates), dihydrochalcone, with their mixture.One or more sweeting agents optionally with strongly depend on selected concrete sweeting agent total amount exist, but usually at 0.005%-5%, the level of optional 0.01%-1%.
Compositions of the present invention optionally can comprise saliva stimulant, prepares this stimulant not affect the effect of bioactivity glass detailed in this article and/or potassium salt, such as, can be used for improving xerostomia.One or more saliva stimulants optionally stimulate effective total amount to exist with saliva.
G. occlusive agent
Occlusive agent of the present invention includes but not limited to bioactivity glass, arginine/calcium carbonate, arginine bicarbonate/calcium carbonate and small particle silicas, or their combination.Term used herein " occlusive agent " refers to any reagent contributing to tooth or dental surface remineralization, or when be applied to dental tissue with prevention and/or repair defects in teeth time, the reagent of deposited compound on tooth surfaces and in dental surface.Such as, for the bioactivity glass of remineralization tooth, such as reactive amorphous calcium compound, comprises amorphous calcium phosphate, amorphous fluorinated calcium phosphate and amorphous calcium carbonate phosphate fluoride.When occlusive agent of the present invention is applied to dental tissue, prevention and/or reparation defects in teeth.
1. bioactivity glass
Compositions of the present invention comprises one or more biological acceptable bioactivity glass usually.
The inorganic glass materials that can form one deck hydroxy carbonate apatite according to the present invention is included but not limited to bioactivity glass for suitable biology of the present invention is acceptable.In one embodiment, Dentrifice composition of the present invention comprises biological activity and the acceptable glass of biology.In one embodiment, described compositions comprises phosphorus sodium calcium silicate.In one embodiment, described compositions comprises the phosphorus sodium calcium silicate that its amount is 1.0% weight-20% weight.In one embodiment, described compositions comprises the phosphorus sodium calcium silicate that its amount is 5.0% weight-15% weight.In one embodiment, described compositions comprises the phosphorus sodium calcium silicate that its amount is 10% weight.
Suitable biology is acceptable can have following composition with bioactivity glass, comprising: the silicon dioxide (SiO of 40% weight-86% weight
2); Sodium oxide (the Na of 0% weight-35% weight
2o); The calcium oxide (CaO) of 4% weight-46% weight; With the phosphorous oxide (P of 1% weight-15% weight
2o
5).Preferably, described biology is acceptable comprises with bioactivity glass: the silicon dioxide (SiO of 40% weight-60% weight
2); Sodium oxide (the Na of 10% weight-30% weight
2o); The calcium oxide (CaO) of 10% weight-30% weight; With the phosphorous oxide (P of 2% weight-8% weight
2o
5).Described oxide can be used as solid solution or mixed oxide or hopcalite to be existed.Be applicable to the acceptable and bioactivity glass of exemplary bio of the present invention comprise
it forms the calcium oxide of silicon dioxide, the sodium oxide of 24.5% weight, the phosphorous oxide of 6% weight and 24.5% weight comprising 45% weight.
In one embodiment, except the oxide of silicon, sodium, phosphorus and calcium, suitable biology is acceptable also can be comprised with composition that is bioactivity glass: CaF
2, B
2o
3, Al
2o
3, MgO and K
2o.In certain embodiments, CaF
2scope be 0% weight-25% weight.B
2o
3preferred scope be 0% weight-10% weight.Al
2o
3preferred scope be 0% weight-4% weight.The preferred scope of MgO is 0% weight-5% weight.K
2the preferred scope of O is 0% weight-8% weight.
Biological " effectively " amount that is acceptable and bioactivity glass is the amount being enough to have the treatment of expectation or preventive effect in the people giving active substance or lower animal experimenter and not having excessive disadvantageous side effect (such as toxicity, stimulation or irritatedly to respond), when using in the manner of the present invention, match with rational income/Hazard ratio.Concrete effective dose becomes along with such as following factor: the concrete disease be treated, the physical qualification of experimenter, the character of simultaneously carrying out treating (if any), concrete active substance, concrete dosage form, the carrier of employing and the dosage of expectation used.
Bioactivity glass of the present invention provides effective material and tooth structure to interact.Biocompatible glass of the present invention is the biocompatible glass that can not trigger disadvantageous immune response.
According to the present invention, find, the bioactivity glass with specified particle diameter can be used in particular for treating above-mentioned disease.Particularly, by wherein little being obtained unexpected result with the compositions of the present invention of very little granule combination.In certain embodiments, such as, the bioactivity glass part of compositions comprises the little granule that can bond with tooth structure (such as, be less than 90 microns), and with less granule (such as, be less than 10) combinationally use, larger adhering to tooth structure and be used as ion reservoir in these granules, and less entering and block the irregular inside of multiple dental structure surface.
In one embodiment, the bioactivity glass that the acceptable and bioactivity glass of biology of the present invention is granular non-interconnected is applicable to.In one embodiment, the particle size range of described glass is less than 90 μm.In one embodiment, the particle size range of described glass is less than 70 μm.In one embodiment, the particle size range of described glass is less than 50 μm.In one embodiment, the particle size range of described glass is less than 40 μm.In one embodiment, the particle size range of described glass is less than 30 μm.In one embodiment, the particle size range of described glass is less than 20 μm.In certain embodiments, the particle diameter of the bioactivity glass part of described compositions is less than 20,10,5,4,3,2,1 microns.
In certain embodiments, in these granules larger (such as, be less than 90 microns to being less than 20 microns) other calcium and the reservoir of phosphorus are provided, the deposition of the calcium phosphate making to continue mineralising or started by little granule (such as, being less than 20 microns to being less than 1 micron).In certain embodiments of the invention, other calcium and phosphorus can by leaching to all tooth structures and granules, these granules be connected to the surface imperfection place of tooth structure inside or such as, at its opening, dential canaliculi.This so provide and continue whole reaction and continue the growth of the less granule in these granules, they block on the inside or opening at this surface imperfection place, and can cause effectively coating or fill surface imperfection place.Because less granule to use up their ion fast due to their higher surface areas, the calcium of this excessive concentrations and the ion of phosphorus make less the reacting in these granules.Their ion will be reacted and discharged to larger in these granules more lentamente due to longer effect.In addition, the dental surface opening at the larger irregular place of mechanical wear kinds of surface in these granules, makes little granule enter and reacts with surface imperfection place.
This effect is highly profitable for multiple application.Such as, in caries prevention or decay, compositions of the present invention can penetrate into the minimum depths at surface imperfection place, and accepts the ion without interruption from neighbouring larger particles, makes to grow after the ion supply of the storage that has it all.This is also very useful in sealing pit and crack, and obtains more effective and longer lasting sealing.
These tubules inaccessible cause such as after periodontal surgery, significantly reducing responsive amount.In certain embodiments, diameter is used to be less than 2 microns and to be greater than the mixture of the granule of 45 microns.Find, this combination obtains effective especially compositions.
In certain embodiments, described biology is acceptable comprises glass composition with bioactivity glass, and such composition comprises following component, by weight:
Composition | % weight |
SiO 2 | 40-60 |
CaO 2 | 10-30 |
Na 2O | 10-35 |
P 2O 5 | 2-8 |
CaF 2 | 0-25 |
B 2O 3 | 0-10 |
In certain embodiments, below form (by weight percentage) and form bioactivity glass:
Composition | % weight |
SiO 2 | 40-60 |
CaO 2 | 10-30 |
Na 2O | 10-35 |
P 2O 5 | 2-8 |
CaF 2 | 0-25 |
B 2O 3 | 0-10 |
K 2O | 0-8 |
MgO | 0-5 |
In multiple embodiments, described bioactivity glass is present in described compositions with the amount of 1% weight-35% weight, 5% weight-30% weight, 10% weight-25% weight, 15% weight-20% weight and 20% weight.
2. arginine bicarbonate/calcium carbonate
In certain embodiments, described occlusive agent comprises the granule of arginine bicarbonate, amino acid complex and calcium carbonate.In certain embodiments, arginine bicarbonate/calcium carbonate is grinding agent.In certain embodiments, described arginine bicarbonate/compound of calcium carbonate produces alkaline environment, connects to strengthen granule further.
In certain embodiments, described arginine-bicarbonate/calcium carbonate composition can resist tooth mineral matter and loses in dental caries and dentin hypersensitiveness.In other embodiments, these arginine-bicarbonates/calcium carbonate composition energy neutralizing acid produces and makes tooth structure remineralization.
In multiple embodiments, described arginine bicarbonate/calcium carbonate is present in described compositions with the amount of 1% weight-35% weight, 5% weight-30% weight, 10% weight-25% weight, 15% weight-20% weight and 20% weight.
3. small particle silicas
In certain embodiments, described occlusive agent comprises silicon dioxide, in some embodiment, is small particle silicas.The compound restorative material being widely used in tooth field in recent years needs to have following character.In certain embodiments, it is 0.01 μm-100 μm, 0.1 μm-50 μm, 1 μm-10 μm and 5 μm that described small particle silicas comprises mean diameter, or the ultra-fine grain of their combination.
In addition, there is small particle silicas and be used as pH buffer agent, make the pH scope of preparation according to the ISO standard, and provide increase inaccessible benefit.When with before consumer compare with clinical trial reference product, external retentivity and dentine electrical conductivity research display significantly improve retentivity, reduce dentine fluid flow and acid resistance.
In multiple embodiments, described small particle silicas is present in described compositions with the amount of 1% weight-35% weight, 5% weight-30% weight, 10% weight-25% weight, 15% weight-20% weight and 20% weight.
H. other active substances
In some embodiments, compositions of the present invention can optionally comprise other active materials, can be effective to prevention or the treatment sclerous tissues in oral cavity or the disease of soft tissue or disease, or prevention or treatment physiological disorder or disease.In some embodiments, described active substance is " systemic activity material ", and it can be effective to treat or prevention is not the disease of oral condition going up in whole or in part.In some embodiments, described active substance is " oral care active ", and it can be effective to treat or prevention disease or provide cosmetic benefit in oral cavity (such as, other sclerous tissueses in tooth, gingiva or oral cavity or soft tissue).Useful oral care active comprises brightening agent, caries preventive agent, tartar control agents, preventing dental plaque agent, periodontal actives, grinding agent, flavorants, tooth desensitizers, saliva stimulant herein, and their combination.
In some embodiments, compositions of the present invention optionally can comprise antibacterial, prepares this antibacterial not affect the effect of bioactivity glass detailed in this article and/or potassium salt.The example of antibacterial includes but not limited to triclosan, cetylpyridinium chloride
with their combination.
In some embodiments, compositions of the present invention comprises nutrient substance, prepares this nutrient substance not affect the effect of bioactivity glass detailed in this article and/or potassium salt.Suitable nutrient substance comprises vitamin, mineral, aminoacid, and their mixture.Vitamin comprises vitamin C and D, vitamin B1, riboflavin, calcium pantothenate, nicotinic acid, folic acid, nicotiamide, vitamin B6, vitamin B12, para-amino benzoic acid, bioflavonoids, and their mixture.Supplementary comprises aminoacid (such as L-Trp, 1B, methionine, threonine, levocarnitine and L-BETAIN), lipotropic (such as choline, inositol, betanin and linoleic acid), and their mixture.
In some embodiments, compositions of the present invention also can contain antistain agent.Suitable antistain agent can include but not limited to: carboxylic acid, amino carboxylate compounds, phosphino-acetic acid, polyvinyl pyrrolidone etc.Described antistain agent can be joined in Dentrifice composition, or can be used as independent compositions and provide, use after dentifrice.
In some embodiments, compositions of the present invention also can comprise the material strengthening bio-vitric and the sedimental surface deposition/retentivity of any obtained HAP, include but not limited to Gantrez, enamel matrix, milk protein (casein), chitosan, pluracareL1220 (ethylene oxide/propylene oxide copolymer), poly(ethylene oxide), PVP, methacrylate, Lac, arginine, and their combination.
III. for the preparation of the method for the oral cavity composition containing polyguanidine compound
By any mode known to persons of ordinary skill in the art, by the modification of polyamine, the synthesis of polyguanidine compound can be realized.Under the aqueous conditions of gentleness, primary amine moiety can be completed expeditiously to guanidine
the conversion of group.In some embodiments, first the method for the preparation of oral cavity composition of the present invention comprises the polymer selecting at least one containing primary amine, as illustrational in flow process 1.
In some embodiments, the described polymer containing primary amine is chitosan, PAH, polyvinylamine, poly-aminoalkyl acrylamide, polyvinyl imidazol, poly-aminoalkyl (methyl) acrylate, polymine, polylysine, poly ornithine compound, and their combination.In some embodiments, next comprise for the preparation of the method for oral cavity composition of the present invention primary amine moiety is on the polymer converted into guanidine
group.
In some embodiments, then the method for the preparation of oral cavity composition of the present invention comprises with certain amount, and at the poly-guanidine of formation
under the condition of gegenion complex, use the titration of gegenion solution.In some embodiments, the method for the preparation of oral cavity composition of the present invention also comprises with certain amount, and gathers guanidine at formation calcium
under the condition of gegenion complex, with guanidine poly-described in the titration of calcium source
gegenion complex.
IV. for preventing or treat the method for periodontal disease and dental caries
The present invention also comprises the method for preventing or treat periodontal disease and dental caries, and described method comprises the oral cavity composition containing polyguanidine compound of delivery treatments effective dose in oral cavity.The treatment effective dose of the oral cavity composition defined by the present invention used herein is the amount preventing or treat the oral cavity composition of periodontal disease and dental caries.In some embodiments, the amount of acid of effective dose for reducing or neutralize the dental plaque that caused by carbohydrate metabolism and produce is treated.In some embodiments, treatment effective dose is by mass action or by being conducive to remineralization, by the solubilising providing calcium to suppress tooth, can reduce the amount of tooth enamel, dentine and cemental demineralization.In some embodiments, by oral cavity composition oral administration of the present invention, and can not go calcification or destroy tooth enamel in addition.
In some embodiments, the method for active component targeting oral epithelium tissue is comprised the oral cavity composition of the present invention of delivery treatments effective dose in oral cavity.In some embodiments, the method for long antibacterial material or sterilization material is kept to comprise the oral cavity composition of the present invention of delivery treatments effective dose in oral cavity after being deposited on brush or rinsing on an oral surface.In some embodiments, the method for delay or prophylaxis of teeth dental caries comprises the oral cavity composition of the present invention of delivery treatments effective dose in oral cavity.In some embodiments, the method for the treatment of or prevention odontohyperesthesia comprises the oral cavity composition of the present invention of delivery treatments effective dose in oral cavity.
In yet another aspect, treat, reduce or prevent the method for odontohyperesthesia to comprise the oral cavity composition of the present invention of delivery treatments effective dose in oral cavity, make compositions contact the surface of tooth, a part of compositions can be incorporated in the opening of dential canaliculi by its mode.In one embodiment, part compositions enters dential canaliculi, and the described compositions wherein having entered tubule effectively blocks (that is, " obturation ") tubule, make Cucumber, mineral, ion, compound etc. by being suppressed or strengthening, cause desensitizing dental.In some embodiments, the method blocking dential canaliculi comprises the oral cavity composition of the present invention of delivery treatments effective dose in oral cavity.In some embodiments, the method for the treatment of carious lesions comprises the oral cavity composition of the present invention of delivery treatments effective dose in oral cavity.In some embodiments, the method for the pulp calcification of exposure is made to comprise the oral cavity composition of the present invention of delivery treatments effective dose in oral cavity.In some embodiments, the method for the pit of tooth or the substrate in crack or all calcifications is made to comprise the oral cavity composition of the present invention of delivery treatments effective dose in oral cavity.
Embodiment
Embodiment 1
The single tube tooth paste product comprising occlusive agent and potassium salt that excellent sensitivity of tooth is alleviated is provided
Exemplary of the present invention comprises the single tube tooth paste product comprising one or more occlusive agents and one or more potassium salt.In an exemplary embodiment, in order to alleviate sooner, use single tube technology, quick occlusive agent such as biological activity and biology acceptable glass (such as, Novamin) and potassium be combined.Find to provide significant external obturation containing the not moisture biological activity of potassium and the acceptable glass formulation of biology.
In another exemplary embodiment, be surprised to find that, by adding commercially available small particle silicas (such as, SorbosilAC-43), described biological activity and the acceptable glass of biology (such as, Novamin) preparation have other inaccessible benefit.
Carry out external dose response research, to determine optimum biological activity inaccessible fast and the acceptable glass of biology (such as, Novamin) level.Preparation is containing the biological activity of 5%, 7.5% and 10% and the product of the acceptable glass of biology (such as, Novamin).By confocal microscope, after 6 times and 10 brushes, evaluate product.After 6 process, 10% biological activity and the significant obturation of the acceptable glass of biology (such as, Novamin) preparation display, and after 10 process, all biological activitys and the acceptable glass of biology (such as, Novamin) level provide significant obturation.See Fig. 1.
In order to improve 5% biological activity and the obturation of the acceptable glass of biology (such as, Novamin) when processing for 6 times, study the external impact adding silicon dioxide (such as, IneosAC43 silicon dioxide).As shown in the confocal microscope images in Fig. 1, add 9% silicon dioxide (such as, IneosAC43 silicon dioxide), significantly improve obturation when 6 process.
The acid resistance of in-vitro evaluation two kinds of leading systems.Dentine disk through 6 process is soaked 1 minute in CokeClassic.Image is shown in Fig. 2.Two kinds of systems all show significant acidproof attack.
Being separated with preventing to increase multiviscosisty, multiple glue being joined this not moisture preparation based on glycerol.In certain embodiments, carboxymethyl cellulose provides best overall mouthfeel.Carbopol (carbopol) provide multiviscosisty, but, give stickiness feeling in certain embodiments.By preparation optimization.All leading preparations are stablized 4 weeks at 40 DEG C.
10% Novamin/20%Pluraflo/CMC (without KCl)
10% Novamin/3.75%KCL/CMC
5% Novamin/3.75%KCL/9%AC43/CMC
Embodiment 2
Illustrate the conductivity data that 10% Novamin toothpaste contrasts with conventional non-blocking silicon dioxide toothpaste in table 1 below, the raising effect of confocal laser microscope image display Novamin dose response and AC43 silicon dioxide.Result is illustrated in Fig. 3.
Table 1: the electrical conductivity measured after by compositions-treated disclosed herein
The invention is not restricted to the scope of specific embodiment disclosed in an embodiment, these embodiments are intended to illustrate a few aspect of the present invention, and functionally equivalent any embodiment within the scope of the invention.In fact, except shown herein and describe those except, various amendment of the present invention be will become apparent to those skilled in the art that and will fall in the scope of claims.
For any list of references quoted, be attached to herein by reference and in full.
Claims (10)
1. an oral cavity composition, described compositions comprises:
A. the polyguanidine compound of formula (I):
Wherein:
X represents the acceptable gegenion in oral cavity;
Z is CH or N;
R
1, R
2and R
3be hydrogen or straight or branched, saturated or undersaturated optional hydroxylated C independently of one another
1-C
16alkyl;
A represents straight or branched, saturated or undersaturated optional hydroxylated C
1-C
16alkyl; Or A represents and is selected from by least one straight or branched, the saturated or undersaturated C that following group optionally replaces
1-C
16alkylidene: hydroxyl, carboxyl, carboxylate group or halogen; The optional alkylidene containing at least one functional group, at least one functional group described is selected from: amine, ether, thioether, ester, amide, carbamate, urea, by C
1-C
8the C that alkyl, hydroxyl or halogen optionally replace
6aryl or C
3-C
8cycloalkyl ring; Or A represents one or more unsubstituted or by C
1-C
8the C of alkyl, hydroxyl or halogen substiuted
6or C
7aryl or C
5-C
7cycloalkyl ring; Or A represents C
10-C
14polyaryl or C
6-C
10multi-ring alkyl chain, it can be selected from following functional group interval by least one: C
1-C
8alkylidene, amine, amide, ether, thioether, hydrogen atom, carbamate or urea;
N represents between 2-5, the integer of 000; With
B. oral cavity acceptable carrier;
Preferred wherein said gegenion is bicarbonate radical (HCO
3 -);
Preferred described compositions also comprises calcium salt;
Preferred described calcium salt is calcium carbonate, one-lime phosphate, dicalcium phosphate, tricalcium phosphate, calcium fluoride, MFP calcium, calcium pyrophosphate sodium, calcium laurate, calcium palmitate, and their combination;
Preferred described calcium salt is calcium carbonate;
Preferred described compositions also comprises phosphorus source;
Preferred described phosphorus source is be selected from following phytate or phytic acid: inositoltriphosphoric acid salt (IP3), inositol tetrakisphosphate salt (IP4), IP5 salt (IP5), phytate (IP6), and their combination;
Preferred described oral cavity composition is dental care products, food and chewing gum.
2. prepare a method for the oral cavity composition of claim 1, described method comprises:
A. select at least one containing the polymer of primary amine;
B. primary amine moiety is on the polymer converted into guanidine
group; With
C. to form the amount of polyguanidine gegenion complex and under the condition forming polyguanidine gegenion complex, to use the titration of gegenion solution;
Preferably the described polymer containing primary amine is chitosan, PAH, polyvinylamine, poly-aminoalkyl acrylamide, polyvinyl imidazol, poly-aminoalkyl (methyl) acrylate, polymine, polylysine, poly ornithine compound, and their combination;
Preferred described gegenion solution is bicarbonate radical (HCO
3 -) solution;
Preferred described polyguanidine gegenion complex is polyguanidine bicarbonate radical complex;
Preferred described method is further comprising the steps of: d. to form the amount of calcium polyguanidine gegenion complex, and under the condition forming calcium polyguanidine gegenion complex, with polyguanidine gegenion complex described in the titration of calcium source;
Preferred described complex is calcium polyguanidine bicarbonate radical complex;
Preferred described calcium source is calcium carbonate, one-lime phosphate, dicalcium phosphate, tricalcium phosphate, calcium fluoride, MFP calcium, calcium pyrophosphate sodium, calcium laurate, calcium palmitate, and their combination;
Preferred described calcium source is calcium carbonate.
3., by a method for active component targeting oral epithelium tissue, described method comprises the oral cavity composition of the claim 1 of delivery treatments effective dose in oral cavity.
4. retain a method for long antibacterial material or sterilization material after being deposited on brush or rinsing on an oral surface, described method comprises the oral cavity composition of the claim 1 of delivery treatments effective dose in oral cavity.
5. a method for delay or prophylaxis of teeth dental caries, described method comprises the oral cavity composition of the claim 1 of delivery treatments effective dose in oral cavity.
6. a method for treatment or prevention odontohyperesthesia, described method comprises the oral cavity composition of the claim 1 of delivery treatments effective dose in oral cavity.
7. block a method for dential canaliculi, described method comprises the oral cavity composition of the claim 1 of delivery treatments effective dose in oral cavity.
8. treat a method for carious lesions, described method comprises the oral cavity composition of the claim 1 of delivery treatments effective dose in oral cavity.
9. make a method for the pulp calcification of exposure, described method comprises the oral cavity composition of the claim 1 of delivery treatments effective dose in oral cavity.
10. make a method for the pit of tooth or the substrate in crack or all calcifications, described method comprises the oral cavity composition of the claim 1 of delivery treatments effective dose in oral cavity.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2009801594451A CN102427795A (en) | 2009-05-18 | 2009-05-18 | Oral compositions containing polyguanidine compounds and methods of making and using the same |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2009801594451A Division CN102427795A (en) | 2009-05-18 | 2009-05-18 | Oral compositions containing polyguanidine compounds and methods of making and using the same |
Publications (1)
Publication Number | Publication Date |
---|---|
CN105412143A true CN105412143A (en) | 2016-03-23 |
Family
ID=55508882
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510570435.4A Pending CN105412143A (en) | 2009-05-18 | 2009-05-18 | Oral cavity composition containing polyguanidine compounds and preparation and application method of oral cavity composition |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105412143A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115297824A (en) * | 2020-03-27 | 2022-11-04 | 高露洁-棕榄公司 | Oral care compositions and methods of use |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1213355A (en) * | 1996-01-29 | 1999-04-07 | 巴尔的摩的马里兰大学 | Bioactive glass compositions and methods of treatment using bioactive glass |
WO2000016712A2 (en) * | 1998-09-24 | 2000-03-30 | Advantage Dental Products, Inc. | Calcified tissue facing preparation containing an antimicrobial agent |
CN101262907A (en) * | 2005-07-15 | 2008-09-10 | 高露洁-棕榄公司 | Oral coompositions having cationic active ingredients |
WO2008140936A2 (en) * | 2007-04-30 | 2008-11-20 | Colgate-Palmolive Company | Oral care composition to reduce or eliminate dental sensitivity |
-
2009
- 2009-05-18 CN CN201510570435.4A patent/CN105412143A/en active Pending
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1213355A (en) * | 1996-01-29 | 1999-04-07 | 巴尔的摩的马里兰大学 | Bioactive glass compositions and methods of treatment using bioactive glass |
WO2000016712A2 (en) * | 1998-09-24 | 2000-03-30 | Advantage Dental Products, Inc. | Calcified tissue facing preparation containing an antimicrobial agent |
CN101262907A (en) * | 2005-07-15 | 2008-09-10 | 高露洁-棕榄公司 | Oral coompositions having cationic active ingredients |
WO2008140936A2 (en) * | 2007-04-30 | 2008-11-20 | Colgate-Palmolive Company | Oral care composition to reduce or eliminate dental sensitivity |
Non-Patent Citations (2)
Title |
---|
《化工百科全书》编辑部: "《化工百科全书》", 31 August 1994, 北京:化学工业出版社 * |
李秀丽等: "新型抗菌剂壳聚糖双胍盐酸盐的抗菌性能研究", 《纺织科技进展》 * |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115297824A (en) * | 2020-03-27 | 2022-11-04 | 高露洁-棕榄公司 | Oral care compositions and methods of use |
US11931443B2 (en) | 2020-03-27 | 2024-03-19 | Colgate-Palmolive Company | Oral care compositions and methods of use |
CN115297824B (en) * | 2020-03-27 | 2024-07-19 | 高露洁-棕榄公司 | Oral care compositions and methods of use |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102427795A (en) | Oral compositions containing polyguanidine compounds and methods of making and using the same | |
TWI391148B (en) | Non-aqueous dentifrice composition with bioacceptable and bioactive glass and methods of use and manufacture thereof | |
TWI469795B (en) | Dual action dentifrice compositions to prevent hypersensitivity and promote remineralization | |
CN102625690B (en) | Oral compositions for treating tooth sensitivity and methods of use and manufacture thereof | |
RU2686753C2 (en) | Tooth paste composition | |
JPS60169423A (en) | Dental plaque prevention and gingivitis prevention | |
CN105412143A (en) | Oral cavity composition containing polyguanidine compounds and preparation and application method of oral cavity composition | |
WO2024104743A1 (en) | Oral care composition | |
EP4331563A1 (en) | Use of oral care composition | |
AU2010232503B2 (en) | Non-aqueous dentifrice composition with bioacceptable and bioactive glass and methods of use and manufacture thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20160323 |
|
RJ01 | Rejection of invention patent application after publication |